WO2002036189A1 - Medicament dispenser - Google Patents
Medicament dispenser Download PDFInfo
- Publication number
- WO2002036189A1 WO2002036189A1 PCT/EP2001/012107 EP0112107W WO0236189A1 WO 2002036189 A1 WO2002036189 A1 WO 2002036189A1 EP 0112107 W EP0112107 W EP 0112107W WO 0236189 A1 WO0236189 A1 WO 0236189A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medicament
- dispenser according
- cassette
- medicament dispenser
- holder
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 310
- 230000007246 mechanism Effects 0.000 claims description 84
- 238000013523 data management Methods 0.000 claims description 25
- 239000000843 powder Substances 0.000 claims description 16
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 14
- GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 7
- 230000037431 insertion Effects 0.000 claims description 7
- 229960004017 salmeterol Drugs 0.000 claims description 7
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 claims description 6
- 210000003811 finger Anatomy 0.000 claims description 6
- 229960000289 fluticasone propionate Drugs 0.000 claims description 6
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 claims description 6
- 229960002052 salbutamol Drugs 0.000 claims description 6
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims description 4
- 239000012453 solvate Substances 0.000 claims description 4
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 claims description 3
- 229950000210 beclometasone dipropionate Drugs 0.000 claims description 3
- 210000003813 thumb Anatomy 0.000 claims description 3
- 229960005018 salmeterol xinafoate Drugs 0.000 claims description 2
- 239000002585 base Substances 0.000 description 51
- 230000008878 coupling Effects 0.000 description 19
- 238000010168 coupling process Methods 0.000 description 19
- 238000005859 coupling reaction Methods 0.000 description 19
- -1 nebule Substances 0.000 description 17
- 238000004804 winding Methods 0.000 description 17
- 238000000034 method Methods 0.000 description 15
- 230000008901 benefit Effects 0.000 description 10
- 238000004891 communication Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 238000007373 indentation Methods 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 238000012384 transportation and delivery Methods 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 238000004377 microelectronic Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 229910021653 sulphate ion Inorganic materials 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 229950000339 xinafoate Drugs 0.000 description 4
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000013475 authorization Methods 0.000 description 3
- 229960004436 budesonide Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 229960002848 formoterol Drugs 0.000 description 3
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 229940092705 beclomethasone Drugs 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229960002714 fluticasone Drugs 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000023504 respiratory system disease Diseases 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 description 1
- AKNNEGZIBPJZJG-MSOLQXFVSA-N (-)-noscapine Chemical compound CN1CCC2=CC=3OCOC=3C(OC)=C2[C@@H]1[C@@H]1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-MSOLQXFVSA-N 0.000 description 1
- UBLVUWUKNHKCJJ-ZSCHJXSPSA-N (2s)-2,6-diaminohexanoic acid;1,3-dimethyl-7h-purine-2,6-dione Chemical compound NCCCC[C@H](N)C(O)=O.O=C1N(C)C(=O)N(C)C2=C1NC=N2 UBLVUWUKNHKCJJ-ZSCHJXSPSA-N 0.000 description 1
- RZMCXMNNXGCFQG-DQEYMECFSA-N (2s)-3-[4-(4-carbamoylpiperidine-1-carbonyl)oxyphenyl]-2-[[(2s)-4-methyl-2-[[2-(2-methylphenoxy)acetyl]amino]pentanoyl]amino]propanoic acid Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(OC(=O)N2CCC(CC2)C(N)=O)=CC=1)C(O)=O)C(=O)COC1=CC=CC=C1C RZMCXMNNXGCFQG-DQEYMECFSA-N 0.000 description 1
- WRRSFOZOETZUPG-FFHNEAJVSA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;hydrate Chemical compound O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC WRRSFOZOETZUPG-FFHNEAJVSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- YREYLAVBNPACJM-UHFFFAOYSA-N 2-(tert-butylamino)-1-(2-chlorophenyl)ethanol Chemical compound CC(C)(C)NCC(O)C1=CC=CC=C1Cl YREYLAVBNPACJM-UHFFFAOYSA-N 0.000 description 1
- LSLYOANBFKQKPT-DIFFPNOSSA-N 5-[(1r)-1-hydroxy-2-[[(2r)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol Chemical compound C([C@@H](C)NC[C@H](O)C=1C=C(O)C=C(O)C=1)C1=CC=C(O)C=C1 LSLYOANBFKQKPT-DIFFPNOSSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- LUKZNWIVRBCLON-GXOBDPJESA-N Ciclesonide Chemical compound C1([C@H]2O[C@@]3([C@H](O2)C[C@@H]2[C@@]3(C[C@H](O)[C@@H]3[C@@]4(C)C=CC(=O)C=C4CC[C@H]32)C)C(=O)COC(=O)C(C)C)CCCCC1 LUKZNWIVRBCLON-GXOBDPJESA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- IJVCSMSMFSCRME-KBQPJGBKSA-N Dihydromorphine Chemical compound O([C@H]1[C@H](CC[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O IJVCSMSMFSCRME-KBQPJGBKSA-N 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- HUYWAWARQUIQLE-UHFFFAOYSA-N Isoetharine Chemical compound CC(C)NC(CC)C(O)C1=CC=C(O)C(O)=C1 HUYWAWARQUIQLE-UHFFFAOYSA-N 0.000 description 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- AKNNEGZIBPJZJG-UHFFFAOYSA-N alpha-noscapine Natural products CN1CCC2=CC=3OCOC=3C(OC)=C2C1C1C2=CC=C(OC)C(OC)=C2C(=O)O1 AKNNEGZIBPJZJG-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 229940065524 anticholinergics inhalants for obstructive airway diseases Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 239000003434 antitussive agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000007883 bronchodilation Effects 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229960003821 choline theophyllinate Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229960003728 ciclesonide Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Natural products C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 231100000305 environmental exposure data Toxicity 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001022 fenoterol Drugs 0.000 description 1
- PJMPHNIQZUBGLI-UHFFFAOYSA-N fentanyl Chemical compound C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 PJMPHNIQZUBGLI-UHFFFAOYSA-N 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960000676 flunisolide Drugs 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000008011 inorganic excipient Substances 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 description 1
- 229960001888 ipratropium Drugs 0.000 description 1
- 229960001268 isoetarine Drugs 0.000 description 1
- 229960001317 isoprenaline Drugs 0.000 description 1
- 229960004958 ketotifen Drugs 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- LMOINURANNBYCM-UHFFFAOYSA-N metaproterenol Chemical compound CC(C)NCC(O)C1=CC(O)=CC(O)=C1 LMOINURANNBYCM-UHFFFAOYSA-N 0.000 description 1
- HNJJXZKZRAWDPF-UHFFFAOYSA-N methapyrilene Chemical compound C=1C=CC=NC=1N(CCN(C)C)CC1=CC=CS1 HNJJXZKZRAWDPF-UHFFFAOYSA-N 0.000 description 1
- 229960001869 methapyrilene Drugs 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- PLPRGLOFPNJOTN-UHFFFAOYSA-N narcotine Natural products COc1ccc2C(OC(=O)c2c1OC)C3Cc4c(CN3C)cc5OCOc5c4OC PLPRGLOFPNJOTN-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 229960004708 noscapine Drugs 0.000 description 1
- 229960002657 orciprenaline Drugs 0.000 description 1
- 239000008012 organic excipient Substances 0.000 description 1
- NVOYVOBDTVTBDX-PMEUIYRNSA-N oxitropium Chemical compound CC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1 NVOYVOBDTVTBDX-PMEUIYRNSA-N 0.000 description 1
- 229960000797 oxitropium Drugs 0.000 description 1
- RLANKEDHRWMNRO-UHFFFAOYSA-M oxtriphylline Chemical compound C[N+](C)(C)CCO.O=C1N(C)C(=O)N(C)C2=C1[N-]C=N2 RLANKEDHRWMNRO-UHFFFAOYSA-M 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- XDRYMKDFEDOLFX-UHFFFAOYSA-N pentamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCOC1=CC=C(C(N)=N)C=C1 XDRYMKDFEDOLFX-UHFFFAOYSA-N 0.000 description 1
- 229960004448 pentamidine Drugs 0.000 description 1
- 229960001802 phenylephrine Drugs 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960005414 pirbuterol Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- MIXMJCQRHVAJIO-TZHJZOAOSA-N qk4dys664x Chemical compound O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O.C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O MIXMJCQRHVAJIO-TZHJZOAOSA-N 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229960002720 reproterol Drugs 0.000 description 1
- WVLAAKXASPCBGT-UHFFFAOYSA-N reproterol Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CCCNCC(O)C1=CC(O)=CC(O)=C1 WVLAAKXASPCBGT-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960001457 rimiterol Drugs 0.000 description 1
- IYMMESGOJVNCKV-SKDRFNHKSA-N rimiterol Chemical compound C([C@@H]1[C@@H](O)C=2C=C(O)C(O)=CC=2)CCCN1 IYMMESGOJVNCKV-SKDRFNHKSA-N 0.000 description 1
- 229950004432 rofleponide Drugs 0.000 description 1
- IXTCZMJQGGONPY-XJAYAHQCSA-N rofleponide Chemical compound C1([C@@H](F)C2)=CC(=O)CC[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O IXTCZMJQGGONPY-XJAYAHQCSA-N 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940065721 systemic for obstructive airway disease xanthines Drugs 0.000 description 1
- 229960000195 terbutaline Drugs 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical compound O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 description 1
- 229940110309 tiotropium Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- 229960000859 tulobuterol Drugs 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0001—Details of inhalators; Constructional features thereof
- A61M15/0021—Mouthpieces therefor
- A61M15/0025—Mouthpieces therefor with caps
- A61M15/0026—Hinged caps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0043—Non-destructive separation of the package, e.g. peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0046—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier
- A61M15/0051—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type of carrier the dosages being arranged on a tape, e.g. strips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/0045—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters
- A61M15/0053—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal
- A61M15/0055—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using multiple prepacked dosages on a same carrier, e.g. blisters characterized by the type or way of disposal the used dosages being coiled
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/008—Electronic counters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
- A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
- A61M15/007—Mechanical counters
- A61M15/0071—Mechanical counters having a display or indicator
- A61M15/0078—Mechanical counters having a display or indicator on a strip
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
- A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
- A61M2016/0021—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
- A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
- A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
- A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
- A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/062—Desiccants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/10—General characteristics of the apparatus with powered movement mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3306—Optical measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/80—General characteristics of the apparatus voice-operated command
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/82—Internal energy supply devices
- A61M2205/8206—Internal energy supply devices battery-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2209/00—Ancillary equipment
- A61M2209/06—Packaging for specific medical equipment
Definitions
- the present invention relates to a medicament dispenser for dispensing medicament.
- the invention particularly relates to an inhalation device for use in dispensing medicament.
- inhalation devices in the administration of medicaments, for example in bronchodilation therapy is well known.
- Such devices generally comprise a body or housing within which a medicament carrier is located.
- Known inhalation devices include those in which the medicament carrier is a blister strip containing a number of discrete doses of powdered medicament.
- Such devices usually contain a mechanism for accessing these doses, usually comprising either piercing means or means to peel the lid sheet away from the base sheet.
- the powdered medicament can then be accessed and inhaled.
- the cassette may be replaced when the medicament carrier is empty.
- the dispenser is therefore 'environmentally friendly' as the majority of the dispenser may be retained and is not disposable. It also allows the retained part of the dispenser to be fitted with additional features such as electronics which may not be cost effective on a completely disposable dispenser.
- the cassette may be easily removed and that a new replacement cassette can be easily inserted. It is also desirable that the operation of the medicament dispenser is straightforward and non-complex and in particular that the number of separate steps involved in preparing the dispenser for use is minimised. It is further desirable that in exceptional circumstances the cassette may be used on its own as a standalone medicament delivery system. This is especially relevant where the dispenser is designed for use in the delivery of medicament in emergency or rescue situations (e.g. asthma attacks) where simplicity and ease of use is paramount.
- the dispensing part e.g. an outlet, perhaps in the form of a mouthpiece
- the cover desirably acts both to prevent build-up of dirt on the dispensing part and to prevent ingress of dirt into the body of the dispenser through the dispensing part, which might then be subject to ingress by a patient. It is also desirable that the cover is in some way attached or mounted to the dispenser to minimise the risk that the cover is misplaced or lost.
- the body of the dispenser to act as a cover for the dispensing part when the dispenser is in storage and that the cassette is movable relative to the body to enable the dispensing part to be uncovered for use by the patient.
- a medicament dispenser for dispensing medicament comprising: a body; a holder, shaped to fit within said body and movable relative to the body; and receivable by said holder, a cassette containing a medicament carrier, wherein movement of the holder relative to the body results in movement of the cassette between a first position and a second position such that the cassette is reversibly removable from the holder when the cassette is in the second position.
- the first position comprises a dispensing position.
- the second position comprises a non-dispensing position. The cassette is therefore only removable from the holder when the cassette is in the non-dispensing position.
- the cassette may have any suitable form including for example, an essentially flat disc form.
- the holder and body may also have any suitable form.
- the holder and body include attachment means to attach the holder to the body.
- said attachment means comprises a snap-fit mechanism.
- the snap-fit mechanism comprises a pin and hole system.
- the holder is pivotally movable relative to the body. In another aspect, the holder is rotationally movable relative to the body. In a further aspect, the holder is slidably movable relative to the body.
- the one or more stops suitably limit movement of the holder relative to the body to no more than about 180° rotational path.
- the dispensing and non- dispensing positions are separated by about 180° rotation, and corresponding stop positions are defined.
- the one or more stops abut against the edge of the body at defined point(s) when it is moved.
- the holder is suitably designed to click into a stop position.
- the stop in the dispensing position the stop abuts or click- engages one body edge, and in the non-dispensing position the stop abuts or click-engages another body edge.
- the one or more stops suitably limit movement of the holder relative to the body to no more than about 180° rotational path.
- the holder additionally comprises a retainer for retaining the cassette therewithin.
- the retainer comprises a catch.
- the catch may for example, comprise a sprung pin which fits into a hole or an integral catch which deforms when pressed allowing removal of the cassette.
- the retainer is child resistant. Child resistance may be realised by having a system which forces the user to perform two actions at once to remove the cassette. Other features of the retainer may include shock or impact resistance, the ability to lock the catch and orientation features to ensure that the cassette can only be inserted one way.
- the retainer should also be easy to manufacture and assemble, be robust, be composed of a minimal number of components and intrude minimally into the space into which the cassette is inserted.
- the holder includes a guide for guiding the insertion of the cassette into the holder.
- said guide comprise guide rails.
- the guide comprises grooves, indentations or other shaping or surface details to define a 'lock and key' relationship between the holder and the cassette.
- Colour guides, arrows and any other surface markings may also be employed.
- the cassette additionally comprises an indexer (e.g. an indexing lever) for indexing the medicament carrier.
- the indexing lever has a finger tab located outside the body of the cassette. The rest of the indexing lever is located within the cassette.
- the indexing lever may have teeth at its tail end and/or teeth along its mid portion.
- the indexing lever is operable (e.g. for emergency use) even when the cassette is not inserted within the holder.
- the cassette additionally comprises a dispensing outlet.
- the dispensing outlet may have any suitable form ranging from a simple orifice to a shaped passage (e.g. cone or tube) to a mouthpiece or nozzle.
- the presence of a dispensing outlet as part of the cassette itself is beneficial in that it enables the cassette to be used in emergencies as a functioning inhaler, even when the cassette is separate from its holder/body.
- the dispensing outlet is extendable. In one aspect, the dispensing outlet extends as the cassette and holder are moved from the non-dispensing position to the dispensing position.
- the dispensing outlet is retractable (e.g. it is reversibly retractable from the cassette).
- the dispensing outlet retracts as the cassette and holder are moved from the dispensing position to the non-dispensing position.
- the dispensing is telescopic in form. In another aspect, the dispensing outlet is fixed.
- the medicament dispenser may also be designed for nasal inhalation of medicament and the dispensing outlet may therefore incorporate a nozzle fnosepiece') as an alternative to a mouthpiece.
- the body covers the dispensing outlet and indexer when the cassette is in the non-dispensing position. This avoids the need for a separate cover and protects the mouthpiece from the ingress of dirt and contaminants during storage.
- the cassette is shaped to prevent its incorrect insertion into the holder.
- the cassette additionally comprises a raised portion to fit against the holder.
- the raised portion is located at the opposite end of the cassette to the mouthpiece and indexing lever and prevents the incorrect insertion of the cassette into the holder since it is too wide to fit into the holder.
- the raised portion is shaped such that it fits against a cut away part of the holder.
- the raised portion includes a section which is raised to define a grip portion.
- the medicament carrier may have any suitable shape or form for the carrying of medicament in a variety of forms including dry powder, granule, aerosol suspension, solution including aqueous solution, capsule, nebule, pellet and tablet carrier form.
- the medicament carrier respectively comprises a capsule; a tablet carrier; an aqueous container; an aerosol container; and a dry powder container.
- the medicament carrier comprises a container for a reservoir of dry powder.
- the cassette additionally requires a meter for metering a dose of medicament.
- the dose meter defines a metering recess, wherein the metering recess communicates with the medicament container to receive a metered volume of powder when the cassette is in the non-dispensing position and the metering recess communicates with the dispensing outlet to allow passage of the metered volume of powder thereto in the dispensing position.
- the medicament carrier comprises an elongate carrier (either linearly or angularly elongate) which may in aspects, be preloaded with medicament.
- the elongate carrier can take a variety of forms but preferably is a tape, web, belt, strip or cord.
- the powdered medicament may be retained on the carrier by electrostatic attraction, Van der Waals forces, physical attraction, mechanical binding, printing e.g. inkjet printing of the dose onto the carrier, wedging or by a cover layer or an overlying layer of the same carrier when the carrier is wound etc.
- One or more surfaces of the carrier and optionally the interior of the carrier may be configured to assist in retaining the particles of powder.
- the medicament carrier comprises a blister pack, suitably in elongate form.
- the medicament carrier comprises a blister strip.
- said blister strip comprises an elongated strip formed from a base sheet having a plurality of recesses spaced along its length and a lid sheet peelably sealed in superposed relationship thereto to define a plurality of blisters, each having therein inhalable medicament in powder form.
- the blisters may contain a tablet or an aqueous solution or suspension.
- the recesses are capsule shaped.
- the recesses are shaped for receipt by a gear or drive mechanism of the cassette.
- the recesses may shaped in the profile of gear teeth or in the profile of belt drive teeth.
- the lid sheet may contain perforations across its width spaced along the strip to allow the lid sheet to concertina when it has passed through the lid driving means.
- the lid sheet and/or base sheet may also optionally contain apertures or holes formed on one or both edges to fit into a sprocket.
- the cassette additionally comprises an internal mechanism for acting on the medicament carrier there within.
- the internal mechanism comprises an indexer for indexing the medicament carrier.
- the internal mechanism comprises a mover for moving the medicament carrier.
- the internal mechanism comprises access means for accessing the medicament carrier (and hence medicament associated therewith or contained there within).
- the body or holder additionally comprises a drive mechanism for driving at least part of the internal mechanism of the cassette.
- the drive mechanism is in one aspect, a manual drive (e.g. actuable by a finger or thumb movement).
- the drive may be a powered (e.g. motor) drive, as described hereinafter, which is located in the body or holder.
- the cassette comprises an (e.g. externally protruding) indexing lever which co-operates with the internal mechanism for accessing the medicament carrier, and may be used without the body or holder if necessary in the event that mechanical or electronic breakdown of the components of the body and holder should occur, or for emergency use of the cassette as a makeshift, but functioning dispenser.
- an indexing lever which co-operates with the internal mechanism for accessing the medicament carrier
- the internal mechanism comprises:
- an opening station for receiving a medicament carrier of the cassette, said medicament carrier having plural individual medicament containers;
- an indexer for indexing an individual medicament container of the medicament carrier for receipt by said opening station
- a dispensing outlet positioned to communicate with said opened container.
- the medicament carrier comprises a blister strip accessible by a peeling action.
- the peelable blister strip comprises a base sheet and lid sheet which may be peeled apart to uncover a pocket in the base sheet.
- the indexer comprises a rotatabie index wheel having a recesses therein, said index wheel being engageable with a medicament carrier in use with said medicament dispenser such that said recesses each receive a respective pocket of the base sheet of a medicament carrier in use with said medicament dispenser.
- the rotatabie index wheel additionally comprises a series of indentations located at its base and spaced in between the recesses.
- the indexer additionally comprises an interlock coupling to couple movement of the lever to the index wheel.
- the interlock coupling reversibly locks the index wheel in place.
- the interlock coupling comprises a foot portion having a toe and a heel, and a tail section.
- the interlock coupling is pivotally mountable to the cassette at its foot portion.
- the toe fits into one of the indentations on the rotatabie index wheel.
- the heel is fittable into the teeth on the lever to lock the lever in place after it has been actuated by the patient.
- the interlock coupling is sprung to bias it towards location of the toe in one of the indentations.
- the indexer comprises a gear and sprocket wherein teeth on the wheel fit into apertures or holes formed on one or both edges of the blister strip.
- the mechanism therefore resembles that of photographic film being advanced through a camera.
- the indexer comprises a plurality of recesses located on the tail end of the indexing lever.
- the recesses are shaped and sized to engage the pockets in the blister strip. Movement of the lever by the patient indexes the strip by one pocket. When the lever is then returned to its rest position the strip is disengaged and will reengage the strip one pocket further along.
- the indexer comprises an index ratchet which is moveable between a locked position whereby said ratchet engages a pocket on said medicament carrier and prevents further peeling thereof, and a release position allowing free movement of said medicament carrier, and actuation of said medicament dispenser actuates the lid driving means of the opener to release said index ratchet from said medicament carrier to allow peeling thereof.
- the lid driving means draws the medicament carrier through the internal accessing mechanism. The indexer stabilises and prevents further movement of the medicament carrier after the required dose of medicament has been dispensed.
- said index ratchet is pivotally mounted on said dispenser.
- the medicament dispenser further comprises an indexing lever for actuating said dispenser.
- said indexing lever comprises cam means for moving said index ratchet between locked and release positions, such that actuation of said lever from a stop position releases said medicament carrier for peeling thereof.
- said indexing lever comprises a lever ratchet for engaging said lid driving means.
- said lid driving means comprises an index gear and a drive gear which are interconnected so that the rotation of one correlates with the rotation of the other.
- the indexer comprises an electronic drive system wherein the strip is driven by a motor.
- the electronic drive system additionally comprises a mechanical clamp to clamp the strip.
- said lid driving means comprises a wheel on which the lid sheet is wound up.
- the dispenser may further comprise a lever stop means to limit the extent of movement of said index lever and thereby said lid driving means, in order to control the length of medicament carrier peeled by said peeling means.
- the dispenser may further comprise compensating means positioned between said opening station and said lid sheet wheel for reducing the length of said lid sheet therebetween to compensate for any increase in the diameter of the effective winding surface of the lid driving means during use of the dispenser.
- the compensating means takes the form of a flexible member.
- the flexible member may take the form of a flexible elongate arm about which the lid sheet is fed. The arm may flex inwards as tension in the lid sheet increases, and thus shorten the length of lid sheet between the opening station and the lid driving means.
- the compensating means takes the form of a spring which reduces in length as tension increase in the lid sheet between the opening station and the lid driving means.
- a piston head is mounted on one end of the spring about which the lid sheet is fed. The other end of the spring may be fixed. As tension in the lid sheet increases the piston is driven down onto the spring.
- the compensating means takes the form of a sprung-loaded tensioner.
- the dispenser may comprise a clutch means to adjust for any increase in the diameter of the effective winding surface of the lid driving means during use of the dispenser.
- the clutch means communicates with the indexing means and the lid driving means, and comprises a gearing surface defining plural gear engagement positions; and plural gear teeth for engaging said plural gear engagement positions, wherein the plural gear teeth are arranged such that at any one time only a single gear tooth engages a single gear engagement position.
- the clutch means acts to compensate for the increase in diameter of said effective winding surface of the lid driving means.
- the clutch means allows for slippage when the tension in the lid sheet is greater than the force required to peel apart the lid sheet and the base sheet.
- the clutch means effectively defines a number of individual gear positions which is greater than the number of gear engagement positions. This is therefore advantageous over a traditional slipping clutch arrangement comprising intermeshing gear wheels, where the effective number of individual gear positions defined is either equal to, or no more than, the number of gear engagement positions defined by one of the gear wheels.
- the clutch means herein is also typically more compact than traditional slipping clutch arrangements e.g. because it enables smaller gearing surfaces to be employed.
- the gearing surface defines from 20 to 100, preferably from 40 to 80 gear engagement positions.
- the number of gear teeth is from 2 to 20, preferably from 3 to 10.
- the gear engagement positions are equally spaced (e.g. equidistantly spaced) and the gear teeth are offset (e.g * . non-equidistantly spaced) relative thereto.
- Such offset arrangement maximises the number of effective individual gear positions which are capable of definition.
- An example of this aspect is a Vernier spring arrangement.
- the gear engagement positions are also equally spaced (e.g. equidistantly spaced) and the gear teeth are located on a wobbling element capable of wobbling the gear teeth to plural offset (e.g. non-equidistantly spaced) positions.
- a wobbling offset arrangement also maximises the number of effective individual gear positions which are capable of being defined.
- An example of this aspect, is the wobbling wheel arrangement described herein.
- the clutch means is non-integral with either of the lid driving means or the indexing means, but forms a separate interconnecting component.
- the gear teeth may be arranged to be in ratchet form (i.e. enabling movement in one direction only).
- the gearing surface and gear teeth are in biased (e.g. sprung) engagement.
- the lid driving means comprise a wheel on which the lid sheet is wound up.
- said wheel has a winding surface which decreases in diameter when tension in the lid sheet increases.
- the wheel comprises a plurality of resiliently flexible arms each extending therefrom at an angle with respect to a radius. The leading end of the lid sheet is looped over one of said resiliently flexible arms to secure the lid sheet to the wheel initially.
- the lid driving means comprise a mangle.
- the lid sheet passes through two rotating wheels which act as a mangle and is gripped at the point of contact with the wheels.
- the used portion of the lid sheet is collected in a chamber after it has passed through the mangle.
- the lid driving means comprise a roller.
- the roller is composed of a polymeric rubber and is positioned next to a guide wall.
- the roller has a smooth surface.
- the roller has a knurled surface. The roller grips the lid sheet as it passes from the point at which it is separated from the base sheet through the space between the roller and the guide wall and the used portion of the lid sheet is then collected in a chamber.
- the roller has the advantage over the mangle described above in that a greater degree of contact between the roller wheel and the lid sheet occurs- the lid sheet is squeezed through the roller and may pass around about 1/3 of the roller wheel. This provides a higher level of grip and pulling force than with a mangle.
- the force required to turn the roller is constant throughout the use of the device and does not vary according to how much of the lid sheet has been peeled away from the base sheet. This is in contrast to the wheel described above where the forces required to turn the wheel may vary due to the fact that the lid sheet is wound around the wheel.
- the lid sheet is not wound around the roller.
- the roller also has the advantage that the lid sheet does not have to be looped around or fixed to the roller before use of the device, therefore simplifying assembly of the device and reducing costs.
- the lid driving means comprise a lid spool.
- the lid spool comprises a toothed wheel with a central upward cylindrical projection on which the lid sheet may be wound when it has been separated from the base sheet.
- the lid spool has teeth around its base which fit into teeth on the lever. The lid spool is therefore driven by the movement of the indexing lever and the lid sheet is pulled away from the base sheet and wound onto the lid spool, causing the rotatabie indexing wheel to turn and index the base strip by one dose.
- the interlock coupling as described above, is moved along the base of the rotatabie indexing wheel until it fits into the next base recess.
- the lid driving means comprise a spiked wheel. As the spiked wheel turns, the lid sheet is pulled over it and the spikes perforate parts of the lid sheet to improve the grip on the lid sheet. The lid sheet then passes out into a chamber where it collects.
- the lid driving means comprise a clamp system.
- the clamp system comprises at least one angled spring which is pivotable at one end and grips the lid sheet at the other end.
- the clamp system is moved in the direction that the lid sheet is to be pulled and grips the lid sheet, pulling it and therefore peeling it away from the base sheet.
- the clamp system is then moved back to its rest position. This results in the spring pivoting and clamping the lid sheet, therefore preventing the lid sheet from being further peeled from the base sheet.
- the lid driving means is operable by an electronic drive system.
- the electronic drive system may also be used in conjunction with a mechanical drive system.
- the electronic drive system is located in either the body or the holder part and the cassette comprises the minimum number of component (i.e. internal mechanism) parts.
- the body/holder including the electronic drive system is designed to be retained by the user and the cassette is sold as a refill/reload component which is discarded after use. By locating the electronic drive system in the body/holder, the amount of electronic components which are discarded is minimised.
- the electronic drive system typically comprises a motor, preferably an electrically-powered motor.
- the motor may provide linear or rotary drive, but in general, rotary motors are most suitable.
- the motor may for example, comprise a DC electric motor, a piezoelectric (PZ) motor, an ultrasonic motor, a solenoid motor or a linear motor.
- the electronic drive system comprises a DC motor, a PZ motor or an ultrasonic motor.
- ultrasonic motors are particularly preferred since they offer advantages over conventional motors in terms of weight, size, noise, cost and torque generated.
- Ultrasonic motors are well known in the art and are commercially available (e.g. BMSTU Technological Cooperation Centre Ltd, Moscow, Russia; Shinsei Corporation, Tokyo, Japan).
- Ultrasonic motors do not use coils or magnets but comprise a piezo-electric ceramic stator which drives a coupled rotor.
- the stator generates ultrasonic vibrations which in turn causes rotation of the rotor.
- regular DC motors are characterised by high speed and low torque, requiring reduction gearing to increase torque, ultrasonic motors attain low speed and high torque, thus eliminating the need for reduction gearing.
- these motors are lightweight and compact, lacking coils and magnets, and are noiseless as the ultrasonic frequencies used are not audible to the human ear.
- the dispenser further comprises actuating means for actuating said electronic drive system.
- Said actuating means may take the form of a switch, push-button, or lever.
- the used portion of the lid sheet may be passed around rollers and fed back onto the used portion of the base sheet after the medicament has been accessed to join back onto the base sheet.
- the lid sheet may be coated with a sticky substance to aid resealing. The use of this mechanism saves space as the used portions of the blister strip will be collected in the same area.
- the coil comprising the unused blister strip may be surrounded by a constant force spring.
- the coil comprising the unused blister strip may be surrounded by an elastomeric band or band comprising a contractible material.
- the constant force spring, elastomeric band or band comprising a contractible material contracts as the coil reduces in size.
- the peeling means additionally comprise a guide for guiding the lid sheet and base sheet along separate paths at the opening station.
- the lid sheet is passed around the guide portion onto the lid driving means.
- the guide comprises a structure fixed in position in the cassette.
- the guide comprises a roller mechanism. The lid sheet is fed over the rollers onto the lid driving means.
- the cassette comprises a first chamber for holding the medicament carrier when charged with medicament and a second chamber to receive the medicament carrier after release of medicament therefrom.
- the medicament carrier may feed from the first chamber into the second chamber by way of the opening (or access) station.
- the first chamber initially houses a charged elongate blister strip and the second chamber receives the used portion of the base sheet after it has been indexed around the index wheel and separated from the lid sheet.
- the first chamber and second chamber are separated by a wall.
- the wall is movable to adjust the size of the first and second chambers.
- the wall is pivotally mountable e.g. the wall is mountable on a pin fixed into the cassette.
- the wall is slidably mountable.
- the wall additionally comprises at least one brush located along its top or bottom side which brush against the top and bottom surfaces of the inside of the cassette.
- the brushes may act to close off the chamber from the rest of the body of the cassette and to prevent any loose powder from entering the rest of the cassette.
- Loose powder may enter the chambers from the used portion of the blister strip if the patient indexes the strip by pressing the lever when they do not intend to take a dose or when they fail to inhale all the powder.
- the wall additionally comprises at least one flexible seal portion located along its top or bottom side.
- the seal may act in the same way as the brushes described above and seal off the chamber from the rest of the body.
- the wall is flexibly movable to adjust the size of the first and second chambers.
- the second chamber is expandable to create space for the growing coil of the used portion of the base sheet.
- the cassette further comprises a third chamber to receive the used portion of the lid sheet and a fourth chamber which houses the index wheel.
- the fourth chamber communicates via a slit, which in turn extends upwardly within a dispensing outlet and communicates with air inlets.
- the internal mechanism additionally comprises a crushing wheel to crush the blister pockets after the medicament has been removed from them.
- the crushing wheel therefore reduces the space, which the used portion of the base sheet takes up.
- At least a portion of the holder and body are shaped for ease of grip by the user.
- operation of the medicament dispenser may be performed with one hand.
- the medicament dispenser comprises an actuation or dose counter for counting the number of actuations of the indexing lever or releases of dose from the cassette.
- the dose counter may count the number of doses left to be taken or the number of doses taken.
- the dose counter is electronic or mechanical.
- the dose counter is located within the cassette.
- the dose counter is external to the cassette.
- the medicament carrier e.g. a blister strip
- the medicament dispenser additionally comprises an electronic data management system.
- the electronic data management system has input/output capability and comprises a memory for storage of data; a microprocessor for performing operations on said data; and a transmitter for transmitting a signal relating to the data or the outcome of an operation on the data.
- the electronic data management system is arranged to be responsive to or activated by the voice of a user.
- the system may be switched on or off in response to a voice command.
- the electronic data management system may be integral with the body.
- the electronic data management system forms part of a base unit which is reversibly associable with the body.
- the medicament dispenser additionally comprises a data input system for user input of data to the electronic data management system.
- the data input system comprises a man machine interface (MMI) preferably selected from a keypad, voice recognition interface, graphical user interface (GUI) or biometrics interface.
- MMI man machine interface
- GUI graphical user interface
- Energy may be conserved by a variety of means to enable the device to operate for longer on a given source of energy, such as a battery. Energy conservation or saving methods have additional advantages in terms of reducing the size requirements of the power source (e.g. battery) and thus the weight and portability of the medicament dispenser.
- a battery e.g. battery
- a variety of energy saving methods is available which generally involve reducing power consumption.
- One such method is to use a clock or timer circuit to switch the power on and off at regular or predetermined intervals.
- the system can selectively switch on/off specific electronic devices, such as visual display units or sensors, in order to power these devices only when they are required to perform a particular sequence of events.
- different electronic devices may be switched on and off at varying intervals and for varying periods under control of the system.
- the power sequencing system may also respond to a sensor, such as a motion or breath sensor, which is activated on use of the device.
- Low power or "micropower” components should be used within the electronics where possible and if a high power device is required for a particular function this should be put into a low power standby mode or switched off when not required. Similar considerations apply in the selection of transducers. Operation at low voltage is desirable since power dissipation generally increases with voltage.
- CMOS complementary metal-oxide-semiconductor
- CMOS complementary metal-oxide-semiconductor
- Supply voltages should also be kept at minimal values consistent with reliable operation because power dissipation in charging internal capacitance's during switching is proportional to the square of the voltage. Where possible, supply voltages should be approximately the same throughout the circuit to prevent current flowing through input protection circuits.
- Logic inputs should not be left floating and circuits should be arranged so that power consumption is minimised in the most usual logic output state. Slow logic transitions are undesirable because they can result in relatively large class-A currents flowing.
- Resistors may be incorporated in the power supply to individual devices in order to minimise current in the event of failure.
- devices that switch between on and off states are preferred to those that allow analog (e.g. linear) control because less power is dissipated in low resistance on states and low current off states.
- linear components e.g. certain types of voltage regulators
- types with low quiescent currents should be selected.
- appropriate reactive components i.e. inductors and capacitors
- the system additionally comprises a visual display unit for display of data from the electronic data management system to the user.
- the display may for example, comprise a screen such as an LED or LCD screen. More preferably the visual display unit is associable with the body of the medicament dispenser.
- the medicament dispenser additionally comprises a datalink for linking to a local data store to enable communication of data between the local data store and the electronic data management system.
- the datastore may also comprise data management, data analysis and data communication capability.
- the datastore may itself form part of a portable device (e.g. a handheld device) or it may be sized and shaped to be accommodated within the patient's home.
- the datastore may also comprise a physical storage area for storage of replacement cassettes.
- the datastore may further comprise a system for refilling medicament from a reservoir of medicament product stored therewithin.
- the datastore may further comprise an electrical recharging system for recharging any electrical energy store on the medicament dispenser, particularly a battery recharging system.
- the datalink may for example enable linking with a docking station, a personal computer, a network computer system or a set-top box by any suitable method including a hard-wired link, an infra red link or any other suitable wireless communications link.
- the medicament dispenser additionally comprises an actuation detector for detecting actuation of the dispensing mechanism wherein said actuation detector transmits actuation data to the electronic data management system.
- the medicament dispenser may additionally comprise a safety mechanism to prevent unintended multiple actuations of the dispensing mechanism.
- the patient is thereby protected from inadvertently receiving multiple doses of medicament in a situation where they take a number of short rapid breaths.
- the safety mechanism imposes a time delay between successive actuations of the release means. The time delay is typically of the order of from three to thirty seconds.
- the medicament dispenser additionally comprises a release detector for detecting release of medicament from the cassette, wherein said release detector transmits release data to the electronic data management system.
- the medicament dispenser additionally comprises a shake detector for detecting shaking of the medicament container (e.g. prior to actuation of the dispensing mechanism), wherein said shake detector transmits shake data to the electronic data management system.
- a shake detector for detecting shaking of the medicament container (e.g. prior to actuation of the dispensing mechanism), wherein said shake detector transmits shake data to the electronic data management system.
- any actuation detector, release detector, or shake detector comprises a sensor for detecting any suitable parameter such as movement.
- Any suitable sensors are envisaged including the use of optical sensors.
- the release detector may sense any parameter affected by release of the medicament such as pressure, temperature, sound, moisture, carbon dioxide concentration and oxygen concentration.
- the medicament dispenser additionally comprises a breath trigger for triggering the dispensing mechanism, said breath trigger being actuable in response to a trigger signal from the electronic data management system.
- the electronic data management system includes a predictive algorithm or look-up table for deriving from the breath data when to transmit the trigger signal.
- a predictive algorithm or look-up table for deriving from the breath data when to transmit the trigger signal.
- a real-time analysis of the patient breath waveform may be made and the trigger point derived by reference to that analysed waveform.
- the electronic data management system includes a predictive algorithm or look-up table for calculating the optimum amount of medicament to dispense.
- the memory on the electronic data management system includes a dose memory for storing dosage data and reference is made to the dose memory in calculating the optimum amount of medicament to dispense.
- the medicament dispenser additionally comprises a selector for selecting the amount of medicament to dispense from said dispensing mechanism.
- the selector is manually operable.
- the selector is operable in response to a signal from the transmitter on the electronic data management system.
- the medicament dispenser comprises in association with a body or holder thereof, a first transceiver for transmitting and receiving data and in association with the medicament carrier, a second transceiver for transmitting and receiving data, wherein data is transferable in two-way fashion from the first transceiver to the second transceiver.
- the data is preferably in digital form and suitable for transfer by electronic or optical means.
- the information is furthermore stored in a form which is readily and accurately transferable.
- the information could for example, include manufacturing and distribution compliance information written to the memory at various points in the manufacturing or distribution process, thereby providing a detailed and readily accessible product history of the dispenser. Such product history information may, for example, be referred to in the event of a product recall.
- the compliance information could, for example, include date and time stamps.
- the information could also include a unique serial number stored in encrypted form or in a password protectable part of the memory which uniquely identifies the product and therefore may assist in the detection and prevention of counterfeiting.
- the information could also include basic product information such as the nature of the medicament and dosing information, customer information such as the name of the intended customer, and distribution information such as the intended product destination.
- the second transceiver On loading or reloading the medicament dispenser with a cassette the second transceiver may, for example, read the unique serial number, batch code and expiry date of the medicament and any other information on the second transceiver. In this way the nature and concentration of the medicament, together with the number of doses used or remaining within the cassette, may be determined. This information can be displayed to the patient on a visual display unit. Other information, such as the number of times the medicament dispenser has been reloaded with a cassette, may also be displayed.
- the same data can be read from the second transceiver and the number of doses remaining or used determined.
- Other information such as the date and time of administration of the drug, or environmental exposure data such as the minimum / maximum temperatures or levels of humidity the cassette has been exposed to, may also be read and displayed to the user.
- activation of the dispenser may be prevented to safeguard the user. Activation may also be prevented if the medicament has been exposed to extreme environmental conditions for periods outwith the manufacturer's guidelines.
- the medicament dispenser may include an electronic data management system having various sensors associated therewith. Any data collected by the sensors or from any data collection system associated with the electronic data management system including a clock or other date/time recorder is transferable.
- Data may be transferred each time the patient uses the device.
- data may be stored in a database memory of the electronic data management system and periodically downloaded to any transceiver.
- a history of the usage of the device may be built up in the memory of a transceiver.
- a history of the usage of the medicament dispenser is transferred to the second transceiver.
- usage history data may be read from the refill and transferred to a healthcare data management system for example comprising a network computer system under the control of a healthcare data manager.
- Methods are envisaged herein whereby the patient is given some sort of reward for returning the refill and making available the data comprised within the second transceiver.
- Methods are also envisaged herein whereby the healthcare data manager is charged for either receipt of the data from the second transceiver or for its use for commercial purposes. Any rewards or charging may be arranged electronically.
- the methods may be enabled by distributed or web-based computer network systems in which any collected data is accessible through a hub on the network.
- the hub may incorporate various security features to ensure patient confidentiality and to allow selective access to information collected dependent upon level of authorisation.
- the level of user authorisation may be allocated primarily to safeguard patient confidentiality. Beyond this the level of user authorisation may also be allocated on commercial terms with for example broader access to the database being authorised in return for larger commercial payments.
- the first and second transceiver each comprise an antenna or equivalent for transmitting or receiving data and connecting thereto a memory.
- the memory will typically comprise an integrated circuit chip.
- Either transceiver may be configured to have a memory structure which allows for large amounts of information to be stored thereon.
- the memory structure can be arranged such that parts of the memory are read-only, being programmed during/after manufacture, other parts are read/write and further parts are password protectable.
- Initial transfer of information (e.g. on manufacture or one dispensing) to or from any transceiver can be arranged to be readily achievable by the use of a reader which is remote from the medicament dispenser, thereby minimising the need for direct product handling.
- the reader can be arranged to simultaneously read or write to the memory of multiple transceivers on multiple medicament dispensers.
- a suitable power source such as a battery, clockwork energy store, solar cell, fuel cell or kinetics-driven cell will be provided as required to any electronic component herein.
- the power source may be arranged to be rechargeable or reloadable.
- data is transferable in two-way fashion between the first and second transceiver without the need for direct physical contact therebetween.
- data is transferable wirelessly between the first and second transceiver.
- the first transceiver is an active transceiver and the second transceiver is a passive transceiver.
- active is used to mean directly-powered and the term passive is used to mean indirectly-powered.
- the tag may be used in combination and/or integrated with other traditional product labelling methods including visual text, machine-readable text, bar codes and dot codes.
- the integrated circuit chip has a preset memory area containing a factory preset, non-changeable, unique data item.
- the preset memory item is most preferably in encrypted form.
- the integrated circuit chip has plural memory areas thereon.
- any memory area is password protected.
- any memory area contains data in encrypted form.
- Electronic methods of checking identity, error detection and data transfer may also be employed.
- the integrated circuit has plural memory areas thereon including a read only memory area containing a unique serial number, which may for example be embedded at the time of manufacture; a read/write memory area which can be made read only once information has been written thereto; and a password protected memory area containing data in encrypted form which data may be of anti-counterfeiting utility.
- the tag is on a carrier and the carrier is mountable on the body or holder of the medicament dispenser or on the cassette.
- the carrier is a flexible label. In another aspect, the carrier is a rigid disc. In a further aspect, the carrier is a rectangular block. In a further aspect, the carrier is a collar ring suitable for mounting to the neck of an aerosol container. Other shapes of carrier are also envisaged.
- the carrier is mouldable or weldable to the cassette or housing.
- the carrier encases the tag. More preferably, the carrier forms a hermetic seal for the tag.
- the carrier comprises an insulating material such as a glass material or, a paper material or an organic polymeric material such as polypropylene.
- the carrier comprises a ferrite material.
- the energy may be in any suitable form including ultrasonic, infrared, radiofrequency, magnetic, optical and laser form. Any suitable channels may be used to channel the energy including fibre optic channels.
- the second transceiver comprises a radiofrequency identifier comprising an antenna for transmitting or receiving radiofrequency energy; and an integrated circuit chip connecting with said antenna
- the first transceiver comprises a reader for said radiofrequency identifier.
- the radiofrequency identifier is a passive transceiver and the reader is an active transceiver.
- the radiofrequency identifier can be any known radiofrequency identifier. Such identifiers are sometimes known as radiofrequency transponders or radiofrequency identification (RFID) tags or labels. Suitable radiofrequency identifiers include those sold by Phillips Semiconductors of the Netherlands under the trade marks Hitag and lcode, those sold by Amtech Systems Corporation of the United States of America under the trade mark Intellitag, and those sold by Texas Instruments of the United States of America under the trade mark Tagit.
- the second transceiver comprises a magnetic label or tag comprising an antenna for transmitting or receiving magnetic field energy; and an integrated circuit chip connecting with said antenna, and the first transceiver comprises a reader for said magnetic label or tag.
- the magnetic label or tag is a passive transceiver and the reader is an active transceiver.
- a suitable magnetic label or tag comprises plural magnetic elements in mutual association whereby the magnetic elements move relative to each other in response to an interrogating magnetic field.
- a magnetic label or tag of this type is described in U.S. Patent No. 4,940,966.
- Another suitable magnetic label or tag comprises a magnetorestrictive element which is readable by application of an interrogating alternating magnetic field in the presence of a magnetic bias field which results in resonance of the magnetorestrictive elements at different predetermined frequencies.
- a magnetic label of this type is described in PCT Patent Application No. WO92/12402.
- Another suitable magnetic label or tag comprising plural discrete magnetically active regions in a linear array is described in PCT Patent Application No. WO96/31790.
- Suitable magnetic labels and tags include those making use of Programmable Magnetic Resonance
- the second transceiver comprises a microelectronic memory chip and the first transceiver comprises a reader for said microelectronic memory chip.
- the microelectronic memory chip may comprise an Electrically Erasable
- Any transceiver herein, particularly a passive transceiver may be mounted on or encased within any suitable inert carrier.
- the carrier may comprise a flexible sheet which may in embodiments be capable of receiving printed text thereon.
- the first transceiver is integral with the body such that a single unit is comprised.
- the first transceiver may for example be encased within or moulded to the body.
- the first transceiver forms part of a base unit which is reversibly associable with the body.
- the base unit may for example, form a module receivable by the body such as a snap-in module.
- the medicament dispenser additionally comprises a communicator for wireless communication with a network computer system to enable transfer of data between the network computer system and the electronic data management system.
- a communicator for wireless communication with a network computer system to enable transfer of data between the network computer system and the electronic data management system.
- Dispensers employing such communicators are described in pending PCT Applications No.s PCT/EP00/09291 (PG3786), PCT/EP00/09293 (PG4029) and PCT/E POO/09292 (PG4159).
- the communicator enables two-way transfer of data between the network computer system and the electronic data management system.
- the data is communicable between the network computer system and the electronic data management system in encrypted form. All suitable methods of encryption or partial encryption are envisaged. Password protection may also be employed.
- the communicator employs radiofrequency or optical signals.
- the communicator communicates with the gateway via a second communications device.
- the second communications device is a telecommunications device, more preferably a cellular phone or pager.
- the communicator communicates with the second communications device using spread spectrum radiofrequency signals.
- a suitable spread spectrum protocol is the Bluetooth (trade mark) standard which employs rapid
- the network computer system comprises a public access network computer system.
- the Internet is one suitable example of a public access network computer system, wherein the point of access thereto can be any suitable entrypoint including an entrypoint managed by an Internet service provider.
- the public access network computer system may also form part of a telecommunications system, which may itself be either a traditional copper wire system, a cellular system or an optical network.
- the network computer system comprises a private access network computer system.
- the private access network system may for example, comprise an Intranet or Extranet which may for example, be maintained by a health service provider or medicament manufacturer.
- the network may for example include password protection; a firewall; and suitable encryption means.
- the communicator enables communication with a user-specific network address in the network computer system.
- the user-specific network address may be selected from the group consisting of a web-site address, an e-mail address and a file transfer protocol address.
- the user-specific network address is accessible to a remote information source such that information from said remote information source can be made available thereto. More preferably, information from the user- specific network address can be made available to the remote information source.
- the remote information source is an emergency assistance provider, for example a hospital accident and emergency service or an emergency helpline or switchboard.
- the information may thus, comprise a distress or emergency assist signal which requests emergency assistance.
- the remote information source is a manufacturer of medicament or medicament delivery systems.
- Information transferred to the system may thus, comprise product update information.
- the system may also be configured to feed information back to the manufacturer relating to system performance.
- the remote information source is a research establishment.
- information may thus be transferred relating to the trial protocol and information relating to patient compliance fed back to the research establishment.
- the remote information source is an environmental monitoring station. Information relating to weather, pollen counts and pollution levels may thus be made accessible to the system.
- the medicament dispenser additionally comprises a geographic positioning system such as a global positioning system or a system which relies on the use of multiple communications signals and a triangulation algorithm.
- the medicament carrier has medicament associated therewith.
- the medicament is selected from the group consisting of albuterol, salmeterol, fluticasone propionate and beclomethasone dipropionate and salts or solvates thereof and any combination thereof.
- said combination comprises salmeterol xinafoate and fluticasone propionate.
- the medicament additionally comprises an excipient.
- said excipient is a sugar.
- a first part of the kit comprises a body; a holder, shaped to fit within said body and movable relative to said body; and within said holder a receiving station for receipt of a cassette.
- a second part of the kit comprises a cassette containing a medicament carrier, wherein the cassette is receivable by the receiving station and movement of the holder relative to the body results in movement of the cassette between a first position and a second position such that the cassette is reversibly removable from the receiving station when the cassette is in the second position.
- the cassette includes an internal mechanism for acting on said medicament carrier, and the body or holder comprises a drive mechanism for driving said internal mechanism of the cassette.
- the internal mechanism comprises an indexer for indexing the medicament carrier; a mover for moving the medicament carrier; and/or access means for accessing the medicament carrier.
- the body or holder additionally comprises a drive mechanism for driving at least part of the internal mechanism of the cassette.
- the drive mechanism is a manual or powered drive mechanism.
- the medicament dispenser may be assembled as follows.
- the holder is snap fitted into the body.
- the cassette is assembled separately.
- the body of the cassette is formed, preferably in two sections with any necessary spindles or integral components formed into the base. Individual components such as indexing wheels, lid winding mechanisms, guide portions etc are then assembled into the base.
- the medicament carrier e.g. an elongate blister pack
- This may be wound into the dispenser before the lid is attached to the cassette and the cassette sealed.
- the cassette may be formed completely apart from a hole left in its side for insertion of the medicament carrier. The hole may then be sealed to complete the cassette. This second method of inserting the medicament carrier into the device has the advantage that it is much simpler.
- Figure 1 shows a perspective view of a medicament dispenser according to the invention with the cassette removed from the holder and body;
- Figure 2 shows a perspective view of the medicament dispenser of Figure 1 with the cassette inserted into the holder and body in the non-dispensing position;
- Figure 4 shows a perspective view of a medicament carrier for use in accord with the present invention
- Figure 5a shows a sectional view of an internal mechanism of a cassette in accord with the present invention with the majority of the medicament carrier unused;
- Figure 5b shows a sectional view of the internal mechanism of the cassette of Figure 5a with the majority of the pockets of the medicament carrier empty
- Figure 6 shows a perspective view of a second internal mechanism in accord with the present invention
- Figures 7a shows a perspective view of a third internal mechanism in accord with the present invention when the lever has not been actuated
- Figure 8 shows a sectional view of an indexing mechanism for use in accord with the present invention
- Figure 9a shows a perspective view of a medicament dispenser, in the form of a holder/body and a refill cassette, in accord with the invention with the cassette removed from the holder/body;
- Figures 9b and 9c show respective side views of the holder/body and cassette of the medicament dispenser of Figure 9a;
- Figure 10 shows a perspective view of a medicament dispenser, in the form of a holder/body and a refill cassette with integral mouthpiece, in accord with the invention with the cassette removed from the holder/body;
- Figure 11 shows a perspective view of a medicament dispenser, in the form of a holder/body and a refill cassette with integral mouthpiece, in accord with the invention with the cassette removed from the holder/body.
- Figure 1 shows a medicament dispenser in accord with the present invention, comprising a body 10, a holder 20, refill cassette 30 and electronic display 15.
- the holder 20 is shaped to fit snugly inside body 10 and is fixed to a point on the body (not shown) about which it rotates. Stops 22, 24 protrude from the holder 20 and prevent the holder 20 from rotating more than about 180° relative to the body 10.
- the stops 22, 24 also provide two defined positions of the holder 20 within the body 10. One position is defined by stop 22 meeting with body edge 12 and the other position defined by stop 24 meeting with body edge 14 when the holder has been rotated relative to the body.
- the area between stops 22 and 24 is shaped to form a thumb or finger grip 26 for the user of the device.
- the holder 20 forms a shell into which the refill cassette 30 snugly fits.
- the refill cassette 30 comprises a shell containing the medicament carrier (not shown) and a mechanism for opening the carrier (not shown) for the medicament to be accessed.
- the refill cassette 30 has a raised portion 32 at one end on both sides along its width so that this part of the refill cassette 30 is at least the same depth as the part of the holder 28 which receives the refill cassette 30. This allows the position of the cassette 30 within the holder 20 to be fixed such that the ridge 32 protrudes from the holder 20 but the rest of the cassette 30 is contained within the holder 20.
- Figure 2 shows the medicament dispenser according to the present invention with the cassette 130 in place in the holder 120 and body 110 in the non- dispensing position.
- the cassette 130 is fixed in place by a catch (not shown).
- the catch can be made to be child resistant to prevent children from removing the cassette 130 from the holder 110.
- the body 110 covers the mouthpiece (not shown) and a separate mouthpiece cover is therefore not required.
- the body 110 also protects the indexing lever (not shown) and this prevents accidental indexing of the medicament carrier (not shown) when the medicament dispenser is not in use.
- Figures 3a and 3b show the medicament dispenser of Figures 1 and 2 with the cassette 230 in place in the holder 220 in the dispensing position.
- the holder 220 has been rotated relative to the body 210 so that stop 224 abuts body edge 212. It can be seen that the holder 220 has cut away portions on its depth to allow access to the indexing lever 235 and the mouthpiece 237.
- Figure 3b also shows the attachment point 213 at which the holder 220 is attached to the body 210.
- FIG. 4 shows a medicament carrier 350 for use herein.
- the medicament carrier comprises a peelable blister strip 352 defining a plurality of pockets 354a, 354b each of which contains a dose of medicament which can be inhaled, in the form of powder.
- the strip comprises a base sheet 356 in which blisters are formed to define the pockets 354a, 354b and a lid sheet 358 which is hermetically sealed to the base sheet except in the region of the blisters in such a manner that the lid sheet 358 and the base sheet 356 can be peeled apart.
- the sheets 356, 358 are sealed to one another over their whole width except for the leading end portions 357, 359 where they are preferably not sealed to one another at all.
- 356 sheets are each preferably formed of a plastics/aluminium laminate and are preferably adhered to one another by heat sealing.
- the strip 352 is shown as having elongate pockets 354a, 354b which run transversely with respect to the length of the strip 352. This is convenient in that it enables a large number of pockets 354a, 354b to be provided in a given strip 352 length.
- the strip 352 may, for example, be provided with sixty or one hundred pockets 354a, 354b but it will be understood that the strip 352 may have any suitable number of pockets 354a, 354b.
- Figures 5a and 5b show an internal mechanism of a cassette 430 containing a medicament carrier 450.
- Figure 5a shows the medicament carrier 450 in the situation where the majority of the pockets 454 are still filled with powder.
- Figure 5b shows the situation where the majority of pockets 454 are empty and most of the lid sheet 458 has been removed from the base sheet 456.
- the internal mechanism comprises an index wheel 460 and a lid-winding wheel 470 for winding the used portion of the lid sheet 458.
- the index wheel 460 has a plurality of recesses 462a, 462b extending parallel with the axis of the wheel.
- the recesses 462a, 462b are spaced at a pitch which is equal to the distance between the centre lines of adjacent pockets 452a, 452b.
- the mechanism of the cassette 430 further comprises a lever 435, which comprises an arcuate wall with a finger tab 437 protruding from the cassette 430 and an arm that extends inwardly from the wall.
- the cassette 430 also includes an area 480 for the medicament carrier 450 to be coiled in prior to use of the doses contained inside it and an area 482 where the used base of the medicament carrier 450 is collected.
- Area 482 contains base winding wheel 490 on which the used portion of the base sheet is wound.
- a movable wall 485 to separate these two areas to form two chambers 480, 482. The movable wall 485 is pushed from the position shown in figure 5a by the growing coil of collected base sheet to the position shown in figure 5b, thereby adjusting the size of the chambers.
- the lid winding wheel shown in figures 5a and 5b takes the form of a collapsible wheel 470.
- the collapsible wheel 470 has a series of resilient arms 472a, 472b radiating from a central shaft 474, each at an angle to a radius.
- the leading end of the lid sheet 458 is looped over one of these resilient arms 472a and the lid sheet 458 is wound onto the collapsible wheel 470 as it is peeled away from the base sheet 456.
- the resilient arms 470a, 470b gradually flex inwardly, and the effect is to keep the external diameter of the reel of wound up lid sheet 458 substantially constant while the internal diameter decreases.
- Guide portion 490 guides the lid sheet from the point at which it is separated from the base sheet to the lid winding wheel.
- Figure 6 shows an alternative internal mechanism of the cassette which substitutes for that shown in Figures 5a and 5b.
- the mechanism is shown without the medicament carrier in place, without the base winding wheel, chambers for housing the medicament carrier or the movable wall to separate the chambers.
- the lever is also not shown.
- the mechanism comprises index wheel 560 and lid winding roller 570.
- the index wheel 560 has a plurality of recesses 562a, 562b spaced at a pitch equal to the distance between the centre lines of adjacent pockets 552a, 552b in the medicament carrier.
- the mechanism also comprises guide portions 590 and 595 which guide the lid and base sheets (not shown) away from each other and toward the base winding wheel (not shown) or lid winding roller 570 as appropriate.
- the used portion of the lid sheet is gripped tightly by the roller 570 as it passes through from the guide portion 590 and is then passed out into the rest of the cassette to collect in a chamber.
- Use of the roller 570 has the advantage over the collapsing wheel in that the leading end of the lid sheet does not need to be tied on but is merely gripped by the roller 570, therefore simplifying the assembly process.
- the user moves the holder relative to the body to move the cassette into the dispensing position and then presses on the finger tab of the lever to cause it to move.
- This leads to rotation of the index wheel which results in rotation of both the base winding wheel and the lid winding wheel, thus peeling the base sheet and lid sheet apart over a distance sufficient to expose a previously unopened pocket opposite the end of the powder outlet.
- the patient can then inhale the powdered medicament through the mouthpiece.
- FIG. 7a and 7b A further alternative internal mechanism is shown in Figures 7a and 7b.
- the mechanism comprises an index wheel 660 and a lid spool 670.
- the lid spool 670 comprises a toothed wheel 672 with a central upward cylindrical projection on which the lid sheet 658 is wound when it has been separated from the base sheet.
- the index wheel 660 is similar to that shown in Figures 5 and 6 and has a plurality of recesses 662a, 662b spaced at a pitch equal to the distance between the centre lines of adjacent pockets 664 in the medicament carrier 650.
- the index wheel 660 however, additionally has a plurality of indentations 664a, 664b which are spaced at intervals in between the recesses 662a, 662b.
- Interlock coupling 665 comprises a foot portion 666 having a toe 667 and a heel 668, and a tail section 669. The interlock coupling 665 is pivotally mountable to the cassette at its foot portion
- the toe 667 of the interlock coupling 665 is shaped to fit in an indentation
- a ratchet pawl is provided on the lid spool 670 to stop the used portion of the lid sheet 658 from unwinding from the lid spool 670 and to ensure that the tension in the wound lid sheet 658 is maintained.
- Figure 7a shows the mechanism when the index lever 640 has been marginally moved from its rest position. It can be seen that the toe 667 of the interlock coupling 665 has just been moved out of an indent 664 in the index wheel 660.
- the heel 668 of the interlock coupling 665 is in contact with the indexing lever
- the tail section 669 of the interlock coupling 665 is in contact with a projection 646 from the index lever 640.
- the unused portion of the blister strip 652 is fed onto the index wheel 660 and the lid sheet 658 is then separated from the base sheet 656 and passes around a roller guide 688 before being wound around the lid spool 670.
- the lid spool 670 is turned by interaction with the teeth on the lever 640, resulting in the lid sheet 658 being peeled away from the base sheet 656 and wound around the lid spool 670.
- the index wheel 660 is turned as the lid sheet 658 is peeled away until the toe 667 of the interlock coupling inserts into the next indentation 664.
- the heel 668 of the interlock coupling 665 moves against the tail end of the indexing lever 640 and interacts with the teeth 644 on this part of the indexing lever 640.
- the tail section 669 of the interlock coupling 665 is swung around the projection 648 on the lever 640 so that the projection 648 gradually travels along the tail section 669 of the interlock coupling 665 towards its middle.
- the positioning of the mechanism when the index lever 640 has been fully moved is shown in Figure 7b.
- the toe 667 of the interlock coupling 665 has been inserted into the next indentation 664 and the heel 668 has fitted into the teeth 644 at the tail end of the indexing lever 640 to lock the lever 640 in place so that it can not be moved any further.
- 650 is aligned with the mouthpiece (not shown) and air inlet (not shown) ready for inhalation by the patient.
- Figure 8 shows a refill cassette with an alternative indexing mechanism herein.
- the mechanism comprises a number of recesses 748a, 748b located on an arm of the indexing lever 740 which protrudes into the cassette 730.
- the recesses 748a, 748b are shaped and sized to engage the pockets in a blister strip (not shown).
- the indexing lever 740 is moved by the patient the blister strip is indexed by one pocket. Resetting the lever 740 back to its rest position results in the lever 740 disengaging the strip temporarily and then reengaging it one pocket further along.
- This mechanism has the advantage in that it is simple and reduces the number of components required within the device, therefore reducing both the overall cost of the device components and the cost of assembling it.
- FIGS 9a to 9c illustrate a medicament dispenser according to another aspect of the present invention.
- the medicament dispenser comprises a body cover 810, a holder 820, refill cassette 830 and electronic display 815.
- the holder 820 is shaped to fit snugly inside body 810 to a point on the body 813 about which it rotates. Stops 822, 824 protrude from the holder 820 to prevent the holder 820 from rotating more than about 110° relative to the body cover 810.
- the stops 822, 824 also provide two defined positions of the holder 820 within the body cover 810. One position is defined by stop 822 meeting with body edge 812 and the other position defined by stop 824 meeting with body edge 814 when the holder has been rotated relative to the body.
- the holder 820 forms a shell into which the refill cassette 830 snugly fits.
- the refill cassette 830 comprises a shell body containing the medicament carrier (not shown) and an internal mechanism for opening the carrier (not shown) for the medicament to be accessed.
- the refill cassette 830 has a mouthpiece 837 arranged such that in use, the mouthpiece 837 protrudes from the holder 820 but the bulk of the cassette 830 is contained within the holder 820.
- FIG 10 illustrates a further medicament dispenser according to another aspect of the present invention.
- the medicament dispenser comprises a body cover 910, a holder 920 and refill cassette 930.
- the holder 920 is shaped to fit snugly inside body 910 to a point on the body (not shown) about which it rotates. Stops 922, 924 protrude from the holder 920 to prevent the holder 920 from rotating more than about 180° relative to the body cover 910.
- the stops 922, 924 also provide two defined positions of the holder 920 within the body cover 910. One position is defined by stop 922 meeting with body edge 912 and the other position defined by stop 924 meeting with body edge 914 when the holder has been rotated relative to the body.
- the holder 920 forms a shell into which the refill cassette 930 snugly fits by way of a side loading engagement.
- the refill cassette 930 comprises a shell body containing the medicament carrier (not shown) and an internal mechanism 932 for opening the carrier for the medicament to be accessed.
- the refill cassette 930 has a mouthpiece 937 arranged such that in use, the mouthpiece 937 protrudes from the holder 920 but the bulk of the cassette 930 is contained within the holder 920.
- FIG 11 illustrates a further medicament dispenser according to another aspect of the present invention.
- the medicament dispenser comprises a body cover 1010, a holder 1020 and refill cassette 1030.
- the holder 1020 is shaped to fit snugly inside body 1010 to a point on the body (not shown) about which it rotates.
- the holder 1020 forms a landing station with which the refill cassette 1030 snugly engages by way of a face-to-face snap-fit 1029a, 1029b engagement. When so engaged, the holder 1020 and the cassette 1030 in combination form the bulk of the overall 'body form' of the medicament dispenser.
- the refill cassette 1030 comprises a shell body containing the medicament carrier (not shown) and an internal mechanism 1032 for opening the carrier for the medicament to be accessed.
- the refill cassette 1030 has a mouthpiece 1037 arranged such that in use, the mouthpiece 1037 protrudes from the dispenser.
- any of the parts of the dispenser or actuator which contact the medicament suspension may be coated with materials such as fluoropolymer materials (e.g. PTFE or FEP) which reduce the tendency of medicament to adhere thereto.
- fluoropolymer materials e.g. PTFE or FEP
- Any movable parts may also have coatings applied thereto which enhance their desired movement characteristics. Frictional coatings may therefore be applied to enhance frictional contact and lubricants
- the medicament dispenser of the invention is suitable for dispensing medicament, particularly for the treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).
- respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD).
- COPD chronic obstructive pulmonary disease
- Appropriate medicaments may thus be selected from, for example, analgesics, e.g., codeine, dihydromorphine, ergotamine, fentanyl or morphine; anginal preparations, e.g., diltiazem; antiallergics, e.g., cromoglycate (eg s the sodium salt), ketotifen or nedocromil (eg as the sodium salt); antiinfectives e.g., cephalosporins, penicillins, streptomycin, sulphonamides, tetracyclines and pentamidine; antihistamines, e.g., methapyrilene; anti- inflammatories, e.g., beclomethasone (eg as the dipropionate ester), fluticasone (eg as the propionate ester), flunisolide, budesonide, rofleponide, mometasone eg as
- ⁇ 4 integrin inhibitors eg (2S)-3-[4-( ⁇ [4- (aminocarbonyl)-1-piperidinyl]carbonyl ⁇ oxy)phenyl]-2-[((2S)-4-methyl-2- ⁇ [2-(2- methylphenoxy) acetyl]amino ⁇ pentanoyl)amino] propanoic acid (e.g as free acid or potassium salt), diuretics, e.g., amiloride; anticholinergics, e.g., ipratropium (eg as bromide), tiotropium, atropine or oxitropium; hormones, e.g., cortisone, hydrocortisone or prednisolone; xanthines, e.g., aminophylline, choline theophyllinate, lysine theophyllinate or theophylline; therapeutic proteins and peptides, e.g., insulin or
- Preferred medicaments are selected from albuterol, salmeterol, fluticasone propionate and beclomethasone dipropionate and salts or solvates thereof, e.g., the sulphate of albuterol and the xinafoate of salmeterol.
- powdered medicament particles suitable for delivery to the bronchial or alveolar region of the lung have an aerodynamic diameter of less than 10 micrometers, preferably less than 6 micrometers. Other sized particles may be used if delivery to other portions of the respiratory tract is desired, such as the nasal cavity, mouth or throat.
- the medicament may be delivered as pure drug, but more appropriately, it is preferred that medicaments are delivered together with excipients (carriers) which are suitable for inhalation.
- excipients include organic excipients such as polysaccharides (i.e.
- lactose is a preferred excipient.
- Particles of the powdered medicament and/or excipient may be produced by conventional techniques, for example by micronisation, milling or sieving. Additionally, medicament and/or excipient powders may be engineered with particular densities, size ranges, or characteristics. Particles may comprise active agents, surfactants, wall forming materials, or other components considered desirable by those of ordinary skill.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002212330A AU2002212330C9 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
JP2002538998A JP4384848B2 (en) | 2000-10-31 | 2001-10-19 | Drug dispenser |
MXPA03003853A MXPA03003853A (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser. |
AU2002212330A AU2002212330B2 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
HU0301446A HUP0301446A2 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser, medicament dosage, medicament dispenser in kit |
US10/415,291 US6880722B2 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
DE60115698T DE60115698T2 (en) | 2000-10-31 | 2001-10-19 | DRUGS DONORS |
KR10-2003-7006023A KR20030045157A (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
AT01980501T ATE311915T1 (en) | 2000-10-31 | 2001-10-19 | MEDICINE DISPENSER |
CA002427145A CA2427145A1 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
IL15544201A IL155442A0 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
BR0115094-4A BR0115094A (en) | 2000-10-31 | 2001-10-19 | Medicine dispenser |
EP01980501A EP1330281B1 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
NO20031915A NO20031915L (en) | 2000-10-31 | 2003-04-29 | Dispensing drug |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0026647.8A GB0026647D0 (en) | 2000-10-31 | 2000-10-31 | Medicament dispenser |
GB0026647.8 | 2000-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002036189A1 true WO2002036189A1 (en) | 2002-05-10 |
Family
ID=9902322
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012107 WO2002036189A1 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
PCT/EP2001/012106 WO2002036188A2 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012106 WO2002036188A2 (en) | 2000-10-31 | 2001-10-19 | Medicament dispenser |
Country Status (22)
Country | Link |
---|---|
US (2) | US6880722B2 (en) |
EP (1) | EP1330281B1 (en) |
JP (2) | JP4384848B2 (en) |
KR (1) | KR20030045157A (en) |
CN (1) | CN1481263A (en) |
AR (1) | AR031162A1 (en) |
AT (2) | ATE311916T1 (en) |
AU (3) | AU2002218250A1 (en) |
BR (1) | BR0115094A (en) |
CA (1) | CA2427145A1 (en) |
CO (1) | CO5300420A1 (en) |
CZ (1) | CZ20031208A3 (en) |
DE (2) | DE60115699T2 (en) |
GB (1) | GB0026647D0 (en) |
HU (1) | HUP0301446A2 (en) |
IL (1) | IL155442A0 (en) |
MX (1) | MXPA03003853A (en) |
NO (1) | NO20031915L (en) |
PL (1) | PL365991A1 (en) |
TW (1) | TW559561B (en) |
WO (2) | WO2002036189A1 (en) |
ZA (1) | ZA200302965B (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003035151A1 (en) * | 2001-10-19 | 2003-05-01 | Glaxo Group Limited | Medicament dispenser |
WO2003090825A1 (en) * | 2002-04-26 | 2003-11-06 | Glaxo Group Limited | Medicament dispenser |
WO2004026378A2 (en) * | 2002-09-17 | 2004-04-01 | Glaxo Group Limited | Method for loading a medicament dispenser with a medicament carrier |
WO2004033298A2 (en) * | 2002-10-04 | 2004-04-22 | Ecolab Inc. | Method and apparatus for using a unit dose dispenser |
WO2005004786A1 (en) * | 2003-07-11 | 2005-01-20 | Glaxo Group Limited | A dispenser |
WO2005004787A1 (en) * | 2003-07-11 | 2005-01-20 | Glaxo Group Limited | A dispenser |
EP1896181A2 (en) * | 2005-06-06 | 2008-03-12 | Cepheid | Method and apparatus for storing and dispensing reagent beads |
FR2909641A1 (en) * | 2006-12-11 | 2008-06-13 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT |
FR2909643A1 (en) * | 2006-12-11 | 2008-06-13 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT |
WO2008084153A2 (en) * | 2006-12-11 | 2008-07-17 | Valois Sas | Fluid product dispensing device |
EP2011538A1 (en) * | 2007-07-06 | 2009-01-07 | Vectura Delivery Devices Limited | Inhaler |
EP2162174A1 (en) * | 2007-07-06 | 2010-03-17 | Boehringer Ingelheim International GmbH | Inhaler |
WO2011129793A1 (en) * | 2010-04-13 | 2011-10-20 | Mahmut Bilgic | Dry powder inhaler mouthpiece button |
WO2011129791A1 (en) * | 2010-04-13 | 2011-10-20 | Mahmut Bilgic | Inhaler comprising blister package |
WO2012072544A1 (en) * | 2010-11-29 | 2012-06-07 | Sanofi-Aventis Deutschland Gmbh | Medicated module for an inhaler |
WO2012041938A3 (en) * | 2010-09-30 | 2012-06-14 | Novartis Ag | Inhaler |
US8336542B2 (en) | 2005-05-16 | 2012-12-25 | Glaxo Group Limited | Fault indicator |
US8584669B2 (en) | 2006-04-13 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhaler |
RU2550668C2 (en) * | 2009-11-11 | 2015-05-10 | Конинклейке Филипс Электроникс Н.В. | Method and device for medication delivery |
USD744087S1 (en) | 2013-10-01 | 2015-11-24 | Mahmut Bilgic | Dry powder inhaler |
US9345848B2 (en) | 2009-10-20 | 2016-05-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
WO2017144386A1 (en) | 2016-02-24 | 2017-08-31 | Boehringer Ingelheim International Gmbh | Inhaler |
US9849255B2 (en) | 2011-11-25 | 2017-12-26 | Mahmut Bilgic | Inhalation device |
EP3300754A1 (en) * | 2016-10-03 | 2018-04-04 | Jabil Circuit (Shanghai) Ltd. | Medication dispenser |
US9937306B2 (en) | 2006-03-27 | 2018-04-10 | Boehringer Ingelheim International Gmbh | Dosage aerosols for the application of pharmaceutical formulations |
EP4137184A1 (en) * | 2021-08-16 | 2023-02-22 | Vectura Delivery Devices Limited | Adherence / compliance monitor for an inhaler |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270305A (en) * | 1989-09-08 | 1993-12-14 | Glaxo Group Limited | Medicaments |
US7171965B2 (en) * | 2000-02-01 | 2007-02-06 | Valois S.A.S. | Breath actuated dry powder inhaler and tape dose strip |
GB0125132D0 (en) * | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Medicament dispenser |
GB0201677D0 (en) * | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
US6935560B2 (en) * | 2002-02-26 | 2005-08-30 | Safety Syringes, Inc. | Systems and methods for tracking pharmaceuticals within a facility |
EP1478320B1 (en) * | 2002-02-26 | 2017-01-25 | MEPS Real-Time, Inc. | System for tracking pharmaceuticals |
US6889690B2 (en) * | 2002-05-10 | 2005-05-10 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages |
US20030089733A1 (en) * | 2002-07-09 | 2003-05-15 | Cain Russell P | Medication monitoring device |
GB0216831D0 (en) * | 2002-07-19 | 2002-08-28 | Glaxo Group Ltd | Medicament dispenser |
EP1534367A1 (en) * | 2002-07-25 | 2005-06-01 | Glaxo Group Limited | Medicament dispenser |
GB0225621D0 (en) * | 2002-11-02 | 2002-12-11 | Glaxo Group Ltd | Medicament carrier |
GB0303870D0 (en) * | 2003-02-20 | 2003-03-26 | Norton Healthcare Ltd | Pre-metered dose magazine for breath-actuated dry powder inhaler |
US20070221218A1 (en) * | 2003-10-27 | 2007-09-27 | Warden Jeffrey A | Dry Powder Drug Containment System Packages with Tabs, Inhalers and Associated Methods |
US7451761B2 (en) * | 2003-10-27 | 2008-11-18 | Oriel Therapeutics, Inc. | Dry powder inhalers, related blister package indexing and opening mechanisms, and associated methods of dispensing dry powder substances |
SE0303570L (en) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Moisture-sensitive medical product |
GB0409197D0 (en) * | 2004-04-24 | 2004-05-26 | Innovata Biomed Ltd | Device |
US20050263153A1 (en) * | 2004-05-28 | 2005-12-01 | Quadrant Technologies Limited | Unit dose dry powder inhaler |
FR2872798B1 (en) * | 2004-07-09 | 2007-10-05 | Valois Sas | BLISTER ASSEMBLY FOR INHALATION DEVICE |
GB0418278D0 (en) * | 2004-08-16 | 2004-09-15 | Glaxo Group Ltd | Medicament dispenser |
US20090065522A1 (en) * | 2004-10-13 | 2009-03-12 | Nadir Benouali | Unit dose compliance monitoring and reporting device and system |
US6973371B1 (en) * | 2004-10-13 | 2005-12-06 | Nadir Benouali | Unit dose compliance monitoring and reporting device and system |
JP2008519984A (en) * | 2004-11-12 | 2008-06-12 | グラクソ グループ リミテッド | Sensor system with acoustic transducer |
JP4904283B2 (en) | 2004-12-01 | 2012-03-28 | アキュショット インク | Needleless syringe |
GB0428169D0 (en) * | 2004-12-23 | 2005-01-26 | 3M Innovative Properties Co | Pressurized inhalation devices |
FR2881119B1 (en) * | 2005-01-25 | 2010-07-30 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT. |
TW200817056A (en) * | 2006-10-14 | 2008-04-16 | Triad Technologies Co Ltd | Inhaler with dosage monitoring function |
AR058290A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | MEDICINAL DISPENSER |
AR058289A1 (en) * | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | COLLECTOR TO BE USED IN MEDICINAL DISPENSER |
AU2007210177C1 (en) | 2006-01-31 | 2012-11-01 | Oriel Therapeutics, Inc. | Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods |
JP5188991B2 (en) * | 2006-03-03 | 2013-04-24 | エスティーシー.ユーエヌエム | Dry powder inhaler with aeroelastic distribution mechanism |
US8127763B2 (en) * | 2006-03-03 | 2012-03-06 | Stc.Unm | Dry powder inhaler with aeroelastic dispersion mechanism |
DE102006023662A1 (en) * | 2006-05-18 | 2007-11-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | inhaler |
US9457161B2 (en) | 2006-05-18 | 2016-10-04 | Boehringer Ingelheim International Gmbh | Inhaler |
US20080077430A1 (en) * | 2006-09-25 | 2008-03-27 | Singer Michael S | Systems and methods for improving medication adherence |
US7726223B2 (en) * | 2006-11-14 | 2010-06-01 | Cb Products, Inc. | Apparatus and methods for accessing packaged medicaments |
GB0622827D0 (en) * | 2006-11-15 | 2006-12-27 | Glaxo Group Ltd | Sheet driver for use in a drug dispenser |
EP1923083A1 (en) * | 2006-11-17 | 2008-05-21 | Sanofi-Aventis Deutschland GmbH | Drive mechanisms for use in drug delivery devices |
EP2115722A4 (en) * | 2007-01-12 | 2011-12-07 | Healthhonors Corp | Behavior modification with intermittent reward |
US8157125B2 (en) | 2007-04-19 | 2012-04-17 | Mts Medication Technologies, Inc. | Systems and methods for removing medication from packaging |
US8579856B2 (en) * | 2007-05-16 | 2013-11-12 | Mystic Pharmaceuticals, Inc. | Unit dose drug delivery platform |
EP2244771A4 (en) * | 2008-01-23 | 2013-11-06 | Astrazeneca Ab | A medicament-containing dispenser provided with a display for presenting indicia to a user |
EP2082767A1 (en) * | 2008-01-24 | 2009-07-29 | Vectura Delivery Devices Limited | Inhaler |
US7946448B1 (en) | 2008-09-30 | 2011-05-24 | John Madey | Pill dispenser |
GB201020130D0 (en) | 2010-11-26 | 2011-01-12 | Vectura Delivery Devices Ltd | Inhaler |
GB2465764A (en) * | 2008-11-27 | 2010-06-02 | Sensidose Ab | Hand held medical dispensing device with agitating element |
EP2198908A1 (en) * | 2008-12-19 | 2010-06-23 | Boehringer Ingelheim International Gmbh | Inhaler |
US20100318218A1 (en) * | 2009-06-15 | 2010-12-16 | Muncy Jr Robert B | Pill Dispenser and Method |
US20110000481A1 (en) * | 2009-07-01 | 2011-01-06 | Anand Gumaste | Nebulizer for infants and respiratory compromised patients |
US9180263B2 (en) * | 2009-07-01 | 2015-11-10 | Microdose Therapeutx, Inc. | Laboratory animal pulmonary dosing device |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
EP2504013A1 (en) | 2009-11-24 | 2012-10-03 | Gilead Sciences, Inc. | Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
CN104338219B (en) * | 2010-01-05 | 2017-10-24 | 微剂量治疗技术公司 | inhalation device and method |
EA026279B1 (en) * | 2010-04-13 | 2017-03-31 | Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. | Inhaler comprising peelable blister package |
WO2011143106A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bi - functional pyrazolopyridine compounds |
AU2011253203A1 (en) | 2010-05-10 | 2012-11-22 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
CN103200980B (en) * | 2010-11-19 | 2016-03-16 | Msd消费保健品公司 | Press an applicator unit and using method thereof |
AU2014253494B2 (en) * | 2010-11-26 | 2016-01-21 | Vectura Delivery Devices Limited | Inhaler |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
WO2012154483A1 (en) | 2011-05-06 | 2012-11-15 | Gilead Sciences, Inc. | Dry powder fosfomycin/tobramycin formulation for inhalation |
AR086745A1 (en) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE |
FR2979058B1 (en) * | 2011-08-19 | 2013-08-30 | Valois Sas | INHALATION DEVICE FOR POWDER. |
SG192310A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
SG192312A1 (en) | 2012-02-02 | 2013-08-30 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling to a medical container |
SG10201800190QA (en) | 2012-02-02 | 2018-02-27 | Becton Dickinson Holdings Pte Ltd | Adaptor for coupling with a medical container |
US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents |
US9199772B2 (en) * | 2012-03-30 | 2015-12-01 | David Krippendorf | Time lockable container and system |
DE102012104850A1 (en) * | 2012-04-05 | 2013-10-10 | Alfred Von Schuckmann | Device for the portioned dispensing of medicaments |
PL2855435T3 (en) | 2012-05-29 | 2018-10-31 | Parion Sciences, Inc. | Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases |
FR2991184B1 (en) * | 2012-05-31 | 2014-07-04 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT. |
JP6195617B2 (en) | 2012-07-05 | 2017-09-13 | ピー.シー.オー.エー. デバイシズ エルティーディー.P.C.O.A. Devices Ltd. | Drug dispenser |
ES2744276T3 (en) | 2012-07-30 | 2020-02-24 | DosentRX Ltd | Container for containing and dispensing solid medicinal pills |
EP2692328A1 (en) | 2012-08-03 | 2014-02-05 | Becton Dickinson France | Dose counting device for coupling with a medical container |
EP2735300A1 (en) | 2012-11-26 | 2014-05-28 | Becton Dickinson France | Adaptor for multidose medical container |
US20140155827A1 (en) | 2012-12-03 | 2014-06-05 | Mylan, Inc. | Medicament information system and method |
US9643770B2 (en) | 2012-12-03 | 2017-05-09 | Mylan Inc. | System and method for medicament storage, dispensing, and administration |
US9692829B2 (en) | 2012-12-03 | 2017-06-27 | Mylan Inc. | Medication delivery system and method |
US9179260B2 (en) | 2012-12-03 | 2015-11-03 | Mylan Inc. | Medicament information system and method |
JP5350530B1 (en) | 2012-12-07 | 2013-11-27 | ニップファーマ株式会社 | Drug inhalation device |
US9593084B2 (en) | 2012-12-17 | 2017-03-14 | Parion Sciences, Inc. | Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity |
WO2014099673A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
CA2896686A1 (en) | 2012-12-17 | 2014-06-26 | Parion Sciences, Inc. | 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds |
EP2908882B1 (en) | 2012-12-21 | 2018-05-23 | Alcon Research, Ltd. | Cassette clamp mechanism |
JP1526207S (en) | 2013-08-05 | 2015-06-15 | ||
CN103523360B (en) * | 2013-10-31 | 2015-08-05 | 北京汇金英和科技有限公司 | For the bottle head made up a prescription |
IL233295B (en) | 2014-06-22 | 2019-11-28 | Ilan Paz | A controlled pill-dispensing system |
EP3501584B2 (en) | 2014-08-28 | 2023-08-30 | Norton (Waterford) Limited | Compliance monitoring module for a breath-actuated inhaler |
WO2016115379A1 (en) | 2015-01-14 | 2016-07-21 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
TWI597079B (en) * | 2015-04-10 | 2017-09-01 | 微劑量醫療公司 | Blister strip advance mechanism |
IL238387B (en) | 2015-04-20 | 2019-01-31 | Paz Ilan | Medication dispenser depilling mechanism |
CN104784051B (en) * | 2015-05-02 | 2017-03-01 | 上海朔茂网络科技有限公司 | A kind of medication follow-up mechanism and its method for tracing |
EP3325060B1 (en) * | 2015-07-20 | 2019-07-03 | Pearl Therapeutics, Inc. | Aerosol delivery systems |
CN108289793A (en) | 2015-10-15 | 2018-07-17 | 东森塔克斯公司 | Image recognition based dosage form dispenser |
WO2017077529A1 (en) | 2015-11-02 | 2017-05-11 | P.C.O.A. | Lockable advanceable oral dosage form dispenser containers |
CN115779207A (en) | 2016-03-24 | 2023-03-14 | 特鲁德尔医学国际公司 | Respiratory care system with electronic indicator |
US10118696B1 (en) | 2016-03-31 | 2018-11-06 | Steven M. Hoffberg | Steerable rotating projectile |
CA3020577C (en) | 2016-05-19 | 2023-08-01 | Trudell Medical International | Smart valved holding chamber |
KR102379921B1 (en) * | 2016-06-08 | 2022-03-29 | 이권각 | Portable Pill Dispenser Device Using Pill Cartridges with Enclosed Pill Strips |
ES2894895T3 (en) | 2016-07-08 | 2022-02-16 | Trudell Medical Int | Intelligent oscillating positive expiratory pressure device |
WO2018071434A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
DE102016120240B3 (en) | 2016-10-24 | 2018-04-26 | Edmund Reichenbach | Automatic medicament dispenser, medicament wheel for this purpose and method of operation |
DE202016105968U1 (en) | 2016-10-24 | 2018-01-25 | Edmund Reichenbach | Automatic medication dispenser |
US10426698B2 (en) * | 2016-12-08 | 2019-10-01 | Breeden Brothers, LLC | Pill container with cap |
MX2019006702A (en) | 2016-12-09 | 2019-08-01 | Trudell Medical Int | Smart nebulizer. |
ES2684403B1 (en) * | 2017-03-31 | 2019-07-09 | Farm Rovi Lab Sa | PROCEDURE FOR GRAVIMETRIC FILLING IN STERILE SOLID CONDITIONS IN A PHARMACEUTICAL CONTAINER AND PHARMACEUTICAL CONTAINER USED IN THE SAME |
WO2018186509A1 (en) * | 2017-04-05 | 2018-10-11 | 주식회사 솔메이트 | Rfid communication device mounted in implantable medical equipment |
CN107233659B (en) * | 2017-05-31 | 2020-05-19 | 麦递途医疗科技(上海)有限公司 | Occupy-place device of dosing |
US10478276B2 (en) * | 2017-08-11 | 2019-11-19 | World Wildlife Fund, Inc. | Pellet delivery mechanism |
CN109956215A (en) * | 2017-12-14 | 2019-07-02 | 湖南中联重科混凝土机械站类设备有限公司 | Charging device |
AU2019205865A1 (en) | 2018-01-04 | 2020-07-16 | Trudell Medical International Inc. | Smart oscillating positive expiratory pressure device |
US11712637B1 (en) | 2018-03-23 | 2023-08-01 | Steven M. Hoffberg | Steerable disk or ball |
CA3095063A1 (en) * | 2018-03-30 | 2019-10-03 | Kimberly-Clark Worldwide, Inc. | Dispenser |
US11395890B2 (en) | 2018-06-04 | 2022-07-26 | Trudell Medical International | Smart valved holding chamber |
US11712175B2 (en) | 2019-08-27 | 2023-08-01 | Trudell Medical International | Smart oscillating positive expiratory pressure device with feedback indicia |
JP6901180B1 (en) | 2020-11-19 | 2021-07-14 | ニップファーマ株式会社 | Drug inhaler and counter mechanism |
CN115645688B (en) * | 2022-11-09 | 2023-10-20 | 江苏童医医疗器械有限公司 | Atomizer capable of preventing bottle mouth from being polluted |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009293A1 (en) | 1978-09-21 | 1980-04-02 | Staat der Nederlanden (Staatsbedrijf der Posterijen, Telegrafie en Telefonie) | Circuit for connecting, at one time, only one of a number of telephone sets to a subscriber's line |
EP0009291A1 (en) | 1978-09-20 | 1980-04-02 | Philips Norden AB | A device for indicating the position of a printer carriage |
EP0009292A1 (en) | 1978-09-20 | 1980-04-02 | Philips Patentverwaltung GmbH | Method and apparatus for determining the internal dimension of extended hollow bodies, especially of tubes |
US4940966A (en) | 1987-06-08 | 1990-07-10 | Scientific Generics Limited | Article detection and/or recognition using magnetic devices |
WO1992012402A1 (en) | 1991-01-04 | 1992-07-23 | Scientific Generics Limited | Remotely readable data storage devices and apparatus |
WO1996031790A1 (en) | 1995-04-04 | 1996-10-10 | Scientific Generics Limited | Spatial magnetic interrogation |
US5755218A (en) * | 1991-03-05 | 1998-05-26 | Aradigm Corporation | Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval |
US5860419A (en) * | 1990-03-02 | 1999-01-19 | Glaxo Group Limited | Inhalation device |
DE19855851A1 (en) * | 1998-06-22 | 1999-12-23 | Alfred Von Schuckmann | New device for extracting powder from cavities in blister packs by suction comprises a suction tube carrier with longitudinal guidance relative to the blister pack carrier |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4733797A (en) * | 1986-09-22 | 1988-03-29 | Haber Terry M | Dosage sealing, monitoring and dispensing assembly |
GB2240758A (en) | 1990-02-13 | 1991-08-14 | Connell Kevin O | Bags |
US5896855A (en) * | 1992-12-24 | 1999-04-27 | Rhone-Poulenc Rorer Limited | Multi dose inhaler apparatus |
US5921237A (en) * | 1995-04-24 | 1999-07-13 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
US5622166A (en) | 1995-04-24 | 1997-04-22 | Dura Pharmaceuticals, Inc. | Dry powder inhaler delivery system |
NZ324374A (en) * | 1996-01-03 | 1999-06-29 | Glaxo Group Ltd | Inhalation device |
SE9700424D0 (en) | 1997-02-07 | 1997-02-07 | Astra Ab | Powder inhales |
US5829435A (en) * | 1997-02-24 | 1998-11-03 | Aradigm Corporation | Prefilter for prevention of clogging of a nozzle in the generation of an aerosol and prevention of administration of undesirable particles |
US5855564A (en) | 1997-08-20 | 1999-01-05 | Aradigm Corporation | Aerosol extrusion mechanism |
US6116238A (en) * | 1997-12-02 | 2000-09-12 | Dura Pharmaceuticals, Inc. | Dry powder inhaler |
ATE432727T1 (en) | 1997-12-02 | 2009-06-15 | Valois Sas | DRY POWDER INHALER |
SE9800897D0 (en) | 1998-03-17 | 1998-03-17 | Astra Ab | Inhalation device |
GB2340758A (en) | 1998-08-21 | 2000-03-01 | Bespak Plc | Drug dispensing system |
SE9900188D0 (en) | 1999-01-22 | 1999-01-22 | Astra Ab | Dispensing device |
AU7780700A (en) | 1999-10-01 | 2001-05-10 | Glaxo Group Limited | Remote patient assessment system |
ATE271400T1 (en) | 1999-10-12 | 2004-08-15 | Shl Medical Ab | INHALER |
GB0125132D0 (en) * | 2001-10-19 | 2001-12-12 | Glaxo Group Ltd | Medicament dispenser |
-
2000
- 2000-10-31 GB GBGB0026647.8A patent/GB0026647D0/en not_active Ceased
-
2001
- 2001-10-19 US US10/415,291 patent/US6880722B2/en not_active Expired - Lifetime
- 2001-10-19 WO PCT/EP2001/012107 patent/WO2002036189A1/en active IP Right Grant
- 2001-10-19 US US10/415,319 patent/US7231920B2/en not_active Expired - Lifetime
- 2001-10-19 AU AU2002218250A patent/AU2002218250A1/en not_active Abandoned
- 2001-10-19 IL IL15544201A patent/IL155442A0/en unknown
- 2001-10-19 PL PL01365991A patent/PL365991A1/en unknown
- 2001-10-19 CA CA002427145A patent/CA2427145A1/en not_active Abandoned
- 2001-10-19 KR KR10-2003-7006023A patent/KR20030045157A/en not_active Application Discontinuation
- 2001-10-19 AT AT01992592T patent/ATE311916T1/en not_active IP Right Cessation
- 2001-10-19 HU HU0301446A patent/HUP0301446A2/en unknown
- 2001-10-19 BR BR0115094-4A patent/BR0115094A/en not_active Application Discontinuation
- 2001-10-19 AU AU2002212330A patent/AU2002212330B2/en not_active Revoked
- 2001-10-19 CZ CZ20031208A patent/CZ20031208A3/en unknown
- 2001-10-19 EP EP01980501A patent/EP1330281B1/en not_active Expired - Lifetime
- 2001-10-19 WO PCT/EP2001/012106 patent/WO2002036188A2/en active IP Right Grant
- 2001-10-19 AU AU2002212330A patent/AU2002212330C9/en not_active Revoked
- 2001-10-19 CN CNA018210074A patent/CN1481263A/en not_active Withdrawn
- 2001-10-19 JP JP2002538998A patent/JP4384848B2/en not_active Expired - Lifetime
- 2001-10-19 JP JP2002538997A patent/JP4188081B2/en not_active Expired - Lifetime
- 2001-10-19 DE DE60115699T patent/DE60115699T2/en not_active Expired - Lifetime
- 2001-10-19 AT AT01980501T patent/ATE311915T1/en not_active IP Right Cessation
- 2001-10-19 MX MXPA03003853A patent/MXPA03003853A/en unknown
- 2001-10-19 DE DE60115698T patent/DE60115698T2/en not_active Expired - Lifetime
- 2001-10-22 CO CO01090639A patent/CO5300420A1/en unknown
- 2001-10-29 AR ARP010105052A patent/AR031162A1/en unknown
- 2001-10-30 TW TW090126881A patent/TW559561B/en not_active IP Right Cessation
-
2003
- 2003-04-15 ZA ZA200302965A patent/ZA200302965B/en unknown
- 2003-04-29 NO NO20031915A patent/NO20031915L/en not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0009291A1 (en) | 1978-09-20 | 1980-04-02 | Philips Norden AB | A device for indicating the position of a printer carriage |
EP0009292A1 (en) | 1978-09-20 | 1980-04-02 | Philips Patentverwaltung GmbH | Method and apparatus for determining the internal dimension of extended hollow bodies, especially of tubes |
EP0009293A1 (en) | 1978-09-21 | 1980-04-02 | Staat der Nederlanden (Staatsbedrijf der Posterijen, Telegrafie en Telefonie) | Circuit for connecting, at one time, only one of a number of telephone sets to a subscriber's line |
US4940966A (en) | 1987-06-08 | 1990-07-10 | Scientific Generics Limited | Article detection and/or recognition using magnetic devices |
US5860419A (en) * | 1990-03-02 | 1999-01-19 | Glaxo Group Limited | Inhalation device |
WO1992012402A1 (en) | 1991-01-04 | 1992-07-23 | Scientific Generics Limited | Remotely readable data storage devices and apparatus |
US5755218A (en) * | 1991-03-05 | 1998-05-26 | Aradigm Corporation | Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval |
WO1996031790A1 (en) | 1995-04-04 | 1996-10-10 | Scientific Generics Limited | Spatial magnetic interrogation |
DE19855851A1 (en) * | 1998-06-22 | 1999-12-23 | Alfred Von Schuckmann | New device for extracting powder from cavities in blister packs by suction comprises a suction tube carrier with longitudinal guidance relative to the blister pack carrier |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003035151A1 (en) * | 2001-10-19 | 2003-05-01 | Glaxo Group Limited | Medicament dispenser |
US7775205B2 (en) | 2001-10-19 | 2010-08-17 | Glaxo Group Limited | Medicament dispenser |
WO2003090825A1 (en) * | 2002-04-26 | 2003-11-06 | Glaxo Group Limited | Medicament dispenser |
JP2005538788A (en) * | 2002-09-17 | 2005-12-22 | グラクソ グループ リミテッド | Method of loading a drug carrier into a drug dispenser |
WO2004026378A2 (en) * | 2002-09-17 | 2004-04-01 | Glaxo Group Limited | Method for loading a medicament dispenser with a medicament carrier |
JP4891545B2 (en) * | 2002-09-17 | 2012-03-07 | グラクソ グループ リミテッド | Method of loading a drug carrier into a drug dispenser |
WO2004026378A3 (en) * | 2002-09-17 | 2004-05-13 | Glaxo Group Ltd | Method for loading a medicament dispenser with a medicament carrier |
US6962266B2 (en) | 2002-10-04 | 2005-11-08 | Ecolab Inc. | Method and apparatus for using a unit dose dispenser |
WO2004033298A2 (en) * | 2002-10-04 | 2004-04-22 | Ecolab Inc. | Method and apparatus for using a unit dose dispenser |
WO2004033298A3 (en) * | 2002-10-04 | 2004-06-10 | Ecolab Inc | Method and apparatus for using a unit dose dispenser |
WO2005004786A1 (en) * | 2003-07-11 | 2005-01-20 | Glaxo Group Limited | A dispenser |
WO2005004787A1 (en) * | 2003-07-11 | 2005-01-20 | Glaxo Group Limited | A dispenser |
US8336542B2 (en) | 2005-05-16 | 2012-12-25 | Glaxo Group Limited | Fault indicator |
EP1896181A2 (en) * | 2005-06-06 | 2008-03-12 | Cepheid | Method and apparatus for storing and dispensing reagent beads |
EP1896181A4 (en) * | 2005-06-06 | 2012-10-17 | Cepheid | Method and apparatus for storing and dispensing reagent beads |
US9937306B2 (en) | 2006-03-27 | 2018-04-10 | Boehringer Ingelheim International Gmbh | Dosage aerosols for the application of pharmaceutical formulations |
US8584669B2 (en) | 2006-04-13 | 2013-11-19 | Boehringer Ingelheim International Gmbh | Inhaler |
WO2008084153A2 (en) * | 2006-12-11 | 2008-07-17 | Valois Sas | Fluid product dispensing device |
FR2909643A1 (en) * | 2006-12-11 | 2008-06-13 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT |
JP2010512213A (en) * | 2006-12-11 | 2010-04-22 | バルワー エス.アー.エス. | Fluid dispenser device |
WO2008078035A3 (en) * | 2006-12-11 | 2009-06-25 | Valois Sas | Fluid product dispensing device |
WO2008078032A3 (en) * | 2006-12-11 | 2008-10-23 | Valois Sas | Fluid product dispensing device |
FR2909641A1 (en) * | 2006-12-11 | 2008-06-13 | Valois Sas | DEVICE FOR DISPENSING FLUID PRODUCT |
US8408201B2 (en) | 2006-12-11 | 2013-04-02 | Aptar France Sas | Fluid product dispensing device |
WO2008078032A2 (en) * | 2006-12-11 | 2008-07-03 | Valois Sas | Fluid product dispensing device |
EP2162174A1 (en) * | 2007-07-06 | 2010-03-17 | Boehringer Ingelheim International GmbH | Inhaler |
EP2011538A1 (en) * | 2007-07-06 | 2009-01-07 | Vectura Delivery Devices Limited | Inhaler |
US8474453B2 (en) | 2007-07-06 | 2013-07-02 | Vectura Delivery Devices Limited | Inhaler |
US10842952B2 (en) | 2009-10-20 | 2020-11-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
US9795750B2 (en) | 2009-10-20 | 2017-10-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
US9795751B2 (en) | 2009-10-20 | 2017-10-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
US9345848B2 (en) | 2009-10-20 | 2016-05-24 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. | Dry powder inhaler |
RU2550668C2 (en) * | 2009-11-11 | 2015-05-10 | Конинклейке Филипс Электроникс Н.В. | Method and device for medication delivery |
WO2011129789A1 (en) * | 2010-04-13 | 2011-10-20 | Mahmut Bilgic | Dry powder inhaler mouthpiece button |
WO2011129791A1 (en) * | 2010-04-13 | 2011-10-20 | Mahmut Bilgic | Inhaler comprising blister package |
WO2011129793A1 (en) * | 2010-04-13 | 2011-10-20 | Mahmut Bilgic | Dry powder inhaler mouthpiece button |
EA026563B1 (en) * | 2010-04-13 | 2017-04-28 | Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. | Dry powder inhaler mouthpiece button |
EA024661B1 (en) * | 2010-04-13 | 2016-10-31 | Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. | Inhaler comprising blister package |
EA024468B1 (en) * | 2010-04-13 | 2016-09-30 | Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. | Dry powder inhaler mouthpiece button |
RU2598465C2 (en) * | 2010-09-30 | 2016-09-27 | Новартис Аг | Inhaler |
WO2012041938A3 (en) * | 2010-09-30 | 2012-06-14 | Novartis Ag | Inhaler |
US9308334B2 (en) | 2010-09-30 | 2016-04-12 | Novartis Ag | Inhaler |
KR101899612B1 (en) | 2010-09-30 | 2018-09-17 | 노파르티스 아게 | Inhaler |
US9427533B2 (en) | 2010-11-29 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Medicated module for an inhaler |
WO2012072544A1 (en) * | 2010-11-29 | 2012-06-07 | Sanofi-Aventis Deutschland Gmbh | Medicated module for an inhaler |
US9849255B2 (en) | 2011-11-25 | 2017-12-26 | Mahmut Bilgic | Inhalation device |
USD744087S1 (en) | 2013-10-01 | 2015-11-24 | Mahmut Bilgic | Dry powder inhaler |
WO2017144386A1 (en) | 2016-02-24 | 2017-08-31 | Boehringer Ingelheim International Gmbh | Inhaler |
US11224705B2 (en) | 2016-02-24 | 2022-01-18 | Boehringer Ingelheim International Gmbh | Inhaler |
EP3300754A1 (en) * | 2016-10-03 | 2018-04-04 | Jabil Circuit (Shanghai) Ltd. | Medication dispenser |
EP4137184A1 (en) * | 2021-08-16 | 2023-02-22 | Vectura Delivery Devices Limited | Adherence / compliance monitor for an inhaler |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1330281B1 (en) | Medicament dispenser | |
US7249687B2 (en) | Medicament dispenser | |
US20190314587A1 (en) | Medicament dispenser | |
US7775205B2 (en) | Medicament dispenser | |
AU2002212330A1 (en) | Medicament dispenser | |
US20050005934A1 (en) | Medicament dispenser | |
US8113199B2 (en) | Counter for use with a medicament dispenser | |
US20050017017A1 (en) | Medicament dispenser | |
US20060163269A1 (en) | Method for loading a medicament dispenser with a medicament carrier | |
AU2002350512A1 (en) | Medicament dispenser | |
US20050172964A1 (en) | Medicament dispenser | |
WO2003090811A2 (en) | Medicament dispenser | |
EP1330282A2 (en) | Medicament dispenser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003/02965 Country of ref document: ZA Ref document number: 155442 Country of ref document: IL Ref document number: 200302965 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 485/KOLNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 525450 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002212330 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001980501 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2427145 Country of ref document: CA Ref document number: 2002538998 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037006023 Country of ref document: KR Ref document number: PA/a/2003/003853 Country of ref document: MX Ref document number: PV2003-1208 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2003-500406 Country of ref document: PH |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037006023 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018210074 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10415291 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001980501 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-1208 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002212330 Country of ref document: AU |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2003-1208 Country of ref document: CZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001980501 Country of ref document: EP |